Two	O
distinct	O
pathways	O
of	O
interleukin-5	B-protein
synthesis	O
in	O
allergen-specific	B-cell_line
human	I-cell_line
T-cell	I-cell_line
clones	I-cell_line
are	O
suppressed	O
by	O
glucocorticoids	O
.	O

Glucocorticoids	O
(	O
GC	O
)	O
have	O
long	O
been	O
used	O
as	O
the	O
most	O
effective	O
agents	O
for	O
the	O
treatment	O
of	O
allergic	O
diseases	O
accompanied	O
by	O
eosinophilia	O
such	O
as	O
chronic	O
asthma	O
and	O
atopic	O
dermatitis	O
.	O

The	O
development	O
of	O
chronic	O
eosinophilic	O
inflammation	O
is	O
dependent	O
on	O
interleukin-5	B-protein
(	O
IL-5	B-protein
)	O
,	O
a	O
selective	B-protein
eosinophil-activating	I-protein
factor	I-protein
,	O
produced	O
by	O
helper	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

To	O
delineate	O
the	O
regulatory	O
mechanisms	O
of	O
human	O
IL-5	B-protein
synthesis	O
,	O
we	O
established	O
allergen-specific	B-cell_line
CD4+	I-cell_line
T-cell	I-cell_line
clones	I-cell_line
from	O
asthmatic	O
patients	O
.	O

GC	O
efficiently	O
suppressed	O
IL-5	B-protein
synthesis	O
of	O
T-cell	O
clones	O
activated	O
via	O
either	O
T-cell	B-protein
receptor	I-protein
(	O
TCR	B-protein
)	O
or	O
IL-2	B-protein
receptor	I-protein
(	O
IL-2R	B-protein
)	O
.	O

Induction	O
of	O
IL-5	B-RNA
mRNA	I-RNA
upon	O
TCR	B-protein
and	O
IL-2R	B-protein
stimulation	O
was	O
totally	O
inhibited	O
by	O
dexamethasone	O
.	O

Human	O
IL-5	B-protein
promoter/enhancer-luciferase	O
gene	O
construct	O
transfected	O
to	O
T-cell	B-cell_line
clones	I-cell_line
was	O
transcribed	O
on	O
either	O
TCR	B-protein
or	O
IL-2R	B-protein
stimulation	O
and	O
was	O
clearly	O
downregulated	O
by	O
dexamethasone	O
,	O
indicating	O
that	O
the	O
approximately	O
500-bp	B-DNA
human	I-DNA
IL-5	I-DNA
gene	I-DNA
segment	I-DNA
located	O
5	B-DNA
'	I-DNA
upstream	I-DNA
of	O
the	O
coding	O
region	O
contains	O
activation-inducible	B-DNA
enhancer	I-DNA
elements	I-DNA
responsible	O
for	O
the	O
regulation	O
by	O
GC	O
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
analysis	O
suggested	O
that	O
AP-1	B-protein
and	O
NF-kappaB	B-protein
are	O
among	O
the	O
possible	O
targets	O
of	O
GC	O
actions	O
on	O
TCR-stimulated	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

NF-AT	B-protein
and	O
NF-kappaB	B-protein
were	O
not	O
significantly	O
induced	O
by	O
IL-2	B-protein
stimulation	O
.	O

Our	O
results	O
showing	O
that	O
GC	O
suppressed	O
IL-5	B-protein
production	O
by	O
human	B-cell_type
CD4+	I-cell_type
T	I-cell_type
cells	I-cell_type
activated	O
by	O
two	O
distinct	O
stimuli	O
,	O
TCR	B-protein
and	O
IL-2R	B-protein
stimulation	O
,	O
underscore	O
the	O
efficacy	O
of	O
GC	O
in	O
the	O
treatment	O
of	O
allergic	O
diseases	O
via	O
suppression	O
of	O
T-cell	O
IL-5	B-protein
synthesis	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Two	NULL
Distinct	NULL
Pathways	NULL
of	NULL
Interleukin-5	NULL
Synthesis	NULL
in	NULL
Allergen-Specific	NULL
Human	NULL
T-Cell	NULL
Clones	NULL
Are	NULL
Suppressed	NULL
by	NULL
Glucocorticoids	NULL
By	NULL
Akio	NULL
Mori	NULL
,	NULL
Osamu	NULL
Kaminuma	NULL
,	NULL
Matsunobu	NULL
Suko	NULL
,	NULL
Satoshi	NULL
Inoue	NULL
,	NULL
Takeo	NULL
Ohmura	NULL
,	NULL
Akihiko	NULL
Hoshino	NULL
,	NULL
Yumiko	NULL
Asakura	NULL
,	NULL
Keiji	NULL
Miyazawa	NULL
,	NULL
Toyokazu	NULL
Yokota	NULL
,	NULL
Yasushi	NULL
Okumura	NULL
,	NULL
Koji	NULL
Ito	NULL
,	NULL
and	NULL
Hirokazu	NULL
Okudaira	NULL
Glucocorticoids	NULL
(	NULL
GC	NULL
)	NULL
have	NULL
long	NULL
been	NULL
used	NULL
as	NULL
the	NULL
most	NULL
effective	NULL
agents	NULL
for	NULL
the	NULL
treatment	NULL
of	NULL
allergic	NULL
diseases	NULL
accompanied	NULL
by	NULL
eosinophilia	NULL
such	NULL
as	NULL
chronic	NULL
asthma	NULL
and	NULL
atopic	NULL
dermatitis	NULL
.	NULL

The	NULL
development	NULL
of	NULL
chronic	NULL
eosinophilic	NULL
inflammation	NULL
is	NULL
dependent	NULL
on	NULL
interleukin-5	NULL
(	NULL
IL-5	NULL
)	NULL
,	NULL
a	NULL
selective	NULL
eosinophil-activating	NULL
factor	NULL
,	NULL
produced	NULL
by	NULL
helper	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
delineate	NULL
the	NULL
regulatory	NULL
mechanisms	NULL
of	NULL
human	NULL
IL-5	NULL
synthe-sis	NULL
,	NULL
we	NULL
established	NULL
allergen-specific	NULL
CD4*	NULL
T-cell	NULL
clones	NULL
from	NULL
asthmatic	NULL
patients	NULL
.	NULL

GC	NULL
efficiently	NULL
suppressed	NULL
IL-5	NULL
synthesis	NULL
of	NULL
T-cell	NULL
clones	NULL
activated	NULL
via	NULL
either	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
or	NULL
IL-2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
IL-5	NULL
mRNA	NULL
upon	NULL
TCR	NULL
and	NULL
IL-2R	NULL
stimulation	NULL
was	NULL
totally	NULL
inhibited	NULL
by	NULL
dexamethasone	NULL
.	NULL

Human	NULL
IL-5	NULL
promoter/enhancer-luciferase	NULL
gene	NULL
construct	NULL
transfected	NULL
to	NULL
T-cell	NULL
clones	NULL
was	NULL
transcribed	NULL
on	NULL
either	NULL
TCR	NULL
NTERLEUKIN-5	NULL
(	NULL
IL-5	NULL
)	NULL
is	NULL
a	NULL
potent	NULL
selective	NULL
growth	NULL
factor	NULL
,	NULL
differentiation	NULL
factor	NULL
,	NULL
activating	NULL
factor	NULL
,	NULL
and	NULL
chemo-tactic	NULL
factor	NULL
for	NULL
human	NULL
eosinophils	NULL
.	NULL
'	NULL

''	NULL
Several	NULL
animal	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
tissue	NULL
infiltration	NULL
of	NULL
eosinophils	NULL
is	NULL
dependent	NULL
on	NULL
IL-5	NULL
produced	NULL
by	NULL
T	NULL
cells	NULL
.	NULL

*	NULL
``	NULL
Persistent	NULL
eosinophilic	NULL
inflammation	NULL
of	NULL
the	NULL
bronchial	NULL
mucosa	NULL
is	NULL
a	NULL
characteristic	NULL
pathologic	NULL
feature	NULL
of	NULL
bronchial	NULL
asthma	NULL
.	NULL
``	NULL

The	NULL
number	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
expressing	NULL
IL-5	NULL
mRNA	NULL
is	NULL
increased	NULL
in	NULL
the	NULL
bronchial	NULL
mucosa	NULL
of	NULL
symptomatic	NULL
asthmatics	NULL
,	NULL
``	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
number	NULL
of	NULL
activated	NULL
eosinophils	NULL
,	NULL
and	NULL
is	NULL
further	NULL
increased	NULL
upon	NULL
allergen	NULL
inhalation	NULL
challenge	NULL
.	NULL
'	NULL

''	NULL
``	NULL
L-5	NULL
is	NULL
the	NULL
predominant	NULL
eosinophil-active	NULL
cytokine	NULL
present	NULL
in	NULL
the	NULL
broncho-alveolar	NULL
lavage	NULL
fluids	NULL
obtained	NULL
during	NULL
allergen-induced	NULL
late-phase	NULL
reaction	NULL
.	NULL
``	NULL

Oral	NULL
prednisolone	NULL
therapy	NULL
reduced	NULL
serum	NULL
IL-5	NULL
concentration	NULL
``	NULL
and	NULL
the	NULL
number	NULL
of	NULL
IL-5	NULL
mRNA-expressing	NULL
cells	NULL
in	NULL
broncho-alveolar	NULL
lavage	NULL
fluid	NULL
,	NULL
``	NULL
*	NULL
in	NULL
parallel	NULL
with	NULL
clinical	NULL
improvement	NULL
.	NULL

Control	NULL
of	NULL
T-cell	NULL
IL-5	NULL
production	NULL
seems	NULL
to	NULL
be	NULL
an	NULL
effective	NULL
strategy	NULL
for	NULL
the	NULL
management	NULL
of	NULL
allergic	NULL
diseases	NULL
characterized	NULL
by	NULL
eosinophilic	NULL
inflammation	NULL
.	NULL

Glucocorticoids	NULL
(	NULL
GC	NULL
)	NULL
have	NULL
long	NULL
been	NULL
considered	NULL
the	NULL
most	NULL
effective	NULL
treatment	NULL
for	NULL
eosinophilic	NULL
disorders	NULL
,	NULL
including	NULL
chronic	NULL
asthma	NULL
.	NULL
``	NULL

The	NULL
efficacy	NULL
of	NULL
GC	NULL
is	NULL
ascribed	NULL
to	NULL
their	NULL
multiple	NULL
pharmacologic	NULL
actions	NULL
,	NULL
one	NULL
of	NULL
which	NULL
is	NULL
the	NULL
suppression	NULL
of	NULL
inflammatory	NULL
cytokine	NULL
production	NULL
.	NULL
``	NULL

''	NULL
We	NULL
and	NULL
others	NULL
reported	NULL
that	NULL
IL-5	NULL
synthesis	NULL
by	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
was	NULL
inhibited	NULL
by	NULL
GC	NULL
in	NULL
vitro	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Because	NULL
of	NULL
the	NULL
mixed	NULL
cell	NULL
preparations	NULL
used	NULL
in	NULL
those	NULL
studies	NULL
,	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
GC	NULL
act	NULL
directly	NULL
on	NULL
T	NULL
cells	NULL
or	NULL
not	NULL
still	NULL
remains	NULL
to	NULL
be	NULL
answered	NULL
.	NULL

It	NULL
is	NULL
well	NULL
known	NULL
that	NULL
GC	NULL
induce	NULL
non-T	NULL
cells	NULL
to	NULL
produce	NULL
anti-inflammatory	NULL
mediators	NULL
,	NULL
eg	NULL
,	NULL
lipocortins	NULL
,	NULL
which	NULL
exhibit	NULL
immunosuppressive	NULL
effects	NULL
on	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
we	NULL
used	NULL
allergen-specific	NULL
human	NULL
T-cell	NULL
clones	NULL
in	NULL
the	NULL
present	NULL
study	NULL
and	NULL
showed	NULL
that	NULL
GC	NULL
directly	NULL
act	NULL
on	NULL
T	NULL
cells	NULL
to	NULL
suppress	NULL
IL-5	NULL
synthesis	NULL
at	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
reported	NULL
that	NULL
human	NULL
helper	NULL
T-cell	NULL
clones	NULL
produce	NULL
IL-5	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
as	NULL
well	NULL
as	NULL
to	NULL
antigenic	NULL
stimulation	NULL
.	NULL
``	NULL

Several	NULL
investigators	NULL
have	NULL
reported	NULL
that	NULL
the	NULL
production	NULL
of	NULL
not	NULL
only	NULL
Th2	NULL
cytokines	NULL
but	NULL
also	NULL
IL-2	NULL
(	NULL
a	NULL
Th1	NULL
cytokine	NULL
)	NULL
by	NULL
infiltrating	NULL
T	NULL
cells	NULL
is	NULL
enhanced	NULL
at	NULL
the	NULL
sites	NULL
of	NULL
allergic	NULL
inflammation	NULL
.	NULL
``	NULL

Locally	NULL
produced	NULL
IL-2	NULL
may	NULL
facilitate	NULL
the	NULL
development	NULL
of	NULL
eosinophilic	NULL
inflammation	NULL
through	NULL
Blood	NULL
,	NULL
Vol	NULL
89	NULL
,	NULL
No	NULL
8	NULL
(	NULL
April	NULL
15	NULL
)	NULL
,	NULL
1997	NULL
:	NULL
pp	NULL
2891-2900	NULL
or	NULL
IL-2R	NULL
stimulation	NULL
and	NULL
was	NULL
clearly	NULL
downregulated	NULL
by	NULL
dexamethasone	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
approximately	NULL
500-bp	NULL
human	NULL
IL-5	NULL
gene	NULL
segment	NULL
located	NULL
5	NULL
'	NULL
upstream	NULL
of	NULL
the	NULL
coding	NULL
region	NULL
contains	NULL
activation-inducible	NULL
enhancer	NULL
elements	NULL
responsible	NULL
for	NULL
the	NULL
regulation	NULL
by	NULL
GC	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
analysis	NULL
suggested	NULL
that	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
among	NULL
the	NULL
possible	NULL
targets	NULL
of	NULL
GC	NULL
actions	NULL
on	NULL
TCR-stimulated	NULL
T	NULL
cells	NULL
.	NULL

NF-AT	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
were	NULL
not	NULL
significantly	NULL
induced	NULL
by	NULL
IL-2	NULL
stimulation	NULL
.	NULL

Our	NULL
results	NULL
showing	NULL
that	NULL
GC	NULL
suppressed	NULL
IL-5	NULL
production	NULL
by	NULL
human	NULL
CD4*	NULL
T	NULL
cells	NULL
activated	NULL
by	NULL
two	NULL
distinct	NULL
stimuli	NULL
,	NULL
TCR	NULL
and	NULL
IL-2R	NULL
stimulation	NULL
,	NULL
underscore	NULL
the	NULL
efficacy	NULL
of	NULL
GC	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
allergic	NULL
diseases	NULL
via	NULL
suppression	NULL
of	NULL
T-cell	NULL
IL-5	NULL
synthesis	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

inducing	NULL
IL-5	NULL
production	NULL
by	NULL
T	NULL
cells	NULL
.	NULL

IL-2	NULL
exerts	NULL
its	NULL
effects	NULL
after	NULL
binding	NULL
with	NULL
its	NULL
receptor	NULL
,	NULL
which	NULL
is	NULL
composed	NULL
of	NULL
three	NULL
subunits	NULL
,	NULL
IL-2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
&	NULL
,	NULL
3	NULL
,	NULL
and	NULL
y	NULL
chain	NULL
.	NULL

``	NULL
``	NULL
*	NULL
``	NULL
The	NULL
IL-2R	NULL
signal	NULL
activates	NULL
multiple	NULL
signal	NULL
transduction	NULL
pathways	NULL
,	NULL
eg	NULL
,	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
,	NULL
``	NULL
PI-3	NULL
kinase	NULL
,	NULL
``	NULL
*	NULL
and	NULL
proto-oncogenes	NULL
.	NULL
``	NULL

The	NULL
signal	NULL
transduced	NULL
by	NULL
IL-2R	NULL
is	NULL
reported	NULL
to	NULL
be	NULL
very	NULL
distinct	NULL
from	NULL
the	NULL
signal	NULL
transduced	NULL
by	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
in	NULL
that	NULL
(	NULL
1	NULL
)	NULL
TCR	NULL
signal	NULL
induces	NULL
Ca**	NULL
influx	NULL
but	NULL
IL-2R	NULL
signal	NULL
does	NULL
not	NULL
,	NULL
``	NULL
``	NULL
(	NULL
2	NULL
)	NULL
TCR	NULL
signal	NULL
induces	NULL
PI	NULL
turnover	NULL
but	NULL
IL-2R	NULL
signal	NULL
does	NULL
not	NULL
,	NULL
``	NULL
``	NULL
(	NULL
3	NULL
)	NULL
TCR	NULL
signal	NULL
induces	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
activation	NULL
but	NULL
IL-2R	NULL
signal	NULL
does	NULL
not	NULL
,	NULL
``	NULL
``	NULL
and	NULL
(	NULL
4	NULL
)	NULL
TCR	NULL
signal	NULL
is	NULL
sensitive	NULL
to	NULL
FK506	NULL
and	NULL
cyclosporin	NULL
,	NULL
but	NULL
IL-2R	NULL
signal	NULL
is	NULL
not	NULL
.	NULL
``	NULL

''	NULL
It	NULL
was	NULL
also	NULL
reported	NULL
that	NULL
TCR-induced	NULL
cytokine	NULL
production	NULL
was	NULL
inhibited	NULL
by	NULL
GC	NULL
at	NULL
quite	NULL
low	NULL
con-centrations	NULL
,	NULL
but	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
the	NULL
proliferation	NULL
of	NULL
murine	NULL
cytotoxic	NULL
T	NULL
cells	NULL
induced	NULL
by	NULL
IL-2	NULL
was	NULL
affected	NULL
only	NULL
marginally	NULL
by	NULL
GC	NULL
,	NULL
``	NULL
suggesting	NULL
that	NULL
the	NULL
TCR	NULL
signal	NULL
is	NULL
mediated	NULL
by	NULL
quite	NULL
distinct	NULL
pathways	NULL
from	NULL
the	NULL
IL-2R	NULL
signal	NULL
.	NULL

So	NULL
it	NULL
is	NULL
now	NULL
an	NULL
intriguing	NULL
question	NULL
as	NULL
to	NULL
whether	NULL
IL-2-induced	NULL
IL-5	NULL
synthesis	NULL
is	NULL
inhibited	NULL
by	NULL
GC	NULL
as	NULL
effectively	NULL
as	NULL
TCR-stimulated	NULL
IL-5	NULL
synthesis	NULL
.	NULL

We	NULL
showed	NULL
here	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
GC	NULL
inhibited	NULL
IL-2-induced	NULL
cytokine	NULL
synthesis	NULL
and	NULL
proliferation	NULL
of	NULL
helper	NULL
T	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
further	NULL
supported	NULL
the	NULL
efficacy	NULL
of	NULL
GC	NULL
for	NULL
the	NULL
treatment	NULL
of	NULL
atopic	NULL
diseases	NULL
by	NULL
acting	NULL
as	NULL
IL-5	NULL
synthesis	NULL
inhibitors	NULL
.	NULL

From	NULL
the	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Physical	NULL
Therapy	NULL
and	NULL
Geriatrics	NULL
,	NULL
Faculty	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Bunkyo-ku	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
the	NULL
Bioscience	NULL
Research	NULL
&	NULL
Development	NULL
Labora-tory	NULL
,	NULL
Asahi	NULL
Breweries	NULL
,	NULL
Ltd	NULL
,	NULL
Ohta-ku	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
.	NULL

Submitted	NULL
September	NULL
9	NULL
,	NULL
1996	NULL
;	NULL
accepted	NULL
December	NULL
2	NULL
,	NULL
1996	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Hirokazu	NULL
Okudaira	NULL
,	NULL
MD	NULL
,	NULL
Phd	NULL
,	NULL
Associate	NULL
Professor	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
and	NULL
Physical	NULL
Therapy	NULL
,	NULL
Faculty	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
7-3-1	NULL
Hongo	NULL
,	NULL
Bunkyo-ku	NULL
,	NULL
Tokyo	NULL
113	NULL
,	NULL
Japan	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/97/8908-0023	NULL
$	NULL
3.00/0	NULL
2891	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2892	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
.	NULL

Hydrocortisone	NULL
,	NULL
prednisolone	NULL
,	NULL
and	NULL
dexamethasone	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemicals	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
dissolved	NULL
in	NULL
ethanol	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
mmol/L	NULL
as	NULL
stock	NULL
solutions	NULL
.	NULL

Anti-CD3	NULL
(	NULL
Leu	NULL
4	NULL
)	NULL
,	NULL
anti-CD4	NULL
(	NULL
Leu	NULL
2	NULL
)	NULL
,	NULL
and	NULL
anti-CD8	NULL
(	NULL
Leu	NULL
3	NULL
)	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
MoAbs	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Anti-CD3	NULL
MoAb	NULL
(	NULL
OKT3	NULL
)	NULL
was	NULL
from	NULL
Ortho	NULL
(	NULL
Raritan	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Phorbol	NULL
12-myristate	NULL
13-acetate	NULL
was	NULL
from	NULL
Sigma	NULL
and	NULL
ionomycin	NULL
was	NULL
from	NULL
Calbiochem	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
rIL-2	NULL
)	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Shionogi	NULL
Pharmaceutical	NULL
Co	NULL
(	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
activity	NULL
of	NULL
the	NULL
recombinant	NULL
material	NULL
for	NULL
IL-2	NULL
was	NULL
approximately	NULL
1	NULL
U/ng	NULL
protein	NULL
.	NULL

Recombinant	NULL
Der	NULL
f	NULL
II	NULL
(	NULL
rDer	NULL
f	NULL
11	NULL
)	NULL
was	NULL
directly	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
using	NULL
the	NULL
Der	NULL
f	NULL
II	NULL
cDNA	NULL
clone	NULL
and	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

AIM-V	NULL
medium	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Gaitherburg	NULL
,	NULL
MD	NULL
)	NULL
was	NULL
used	NULL
for	NULL
T-cell	NULL
cultures	NULL
.	NULL

RPMI	NULL
1640	NULL
medium	NULL
(	NULL
GIBCO	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
100	NULL
pg/mL	NULL
.	NULL

streptomycin	NULL
,	NULL
and	NULL
100	NULL
U/mL	NULL
penicillin	NULL
was	NULL
used	NULL
for	NULL
the	NULL
transient	NULL
transfection	NULL
experiments	NULL
.	NULL

Establishment	NULL
of	NULL
antigen-specific	NULL
T-cell	NULL
clones	NULL
.	NULL

-	NULL
Der	NULL
f	NULL
-specific	NULL
human	NULL
T-cell	NULL
clones	NULL
were	NULL
derived	NULL
from	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
of	NULL
atopic	NULL
asthmatic	NULL
patients	NULL
by	NULL
antigen	NULL
stimulation	NULL
followed	NULL
by	NULL
the	NULL
limiting	NULL
dilution	NULL
method	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
PBMC	NULL
(	NULL
2	NULL
x	NULL
10®/mL	NULL
)	NULL
were	NULL
cultured	NULL
with	NULL
rDer	NULL
fI	NULL
protein	NULL
(	NULL
1	NULL
pg/mL	NULL
)	NULL
for	NULL
10	NULL
days	NULL
in	NULL
24-well	NULL
culture	NULL
plates	NULL
and	NULL
nonadherent	NULL
cells	NULL
were	NULL
recovered	NULL
.	NULL

to	NULL
10°	NULL
live	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
96-well	NULL
round-bottom	NULL
culture	NULL
plates	NULL
(	NULL
Nunc	NULL
,	NULL
Roskilde	NULL
,	NULL
Denmark	NULL
)	NULL
with	NULL
antigen	NULL
and	NULL
2,500-rad-irradiated	NULL
autologous	NULL
PBMC	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
.	NULL

Fresh	NULL
medium	NULL
containing	NULL
10	NULL
U/mL	NULL
rIL-2	NULL
was	NULL
added	NULL
once	NULL
weekly	NULL
.	NULL

When	NULL
less	NULL
than	NULL
1	NULL
of	NULL
10	NULL
wells	NULL
contained	NULL
proliferating	NULL
cells	NULL
,	NULL
the	NULL
resulting	NULL
cell	NULL
lines	NULL
were	NULL
considered	NULL
to	NULL
have	NULL
originated	NULL
from	NULL
a	NULL
single	NULL
clone	NULL
.	NULL

To	NULL
ensure	NULL
their	NULL
clonality	NULL
,	NULL
these	NULL
T-cell	NULL
clones	NULL
were	NULL
further	NULL
subcloned	NULL
by	NULL
limiting	NULL
dilution	NULL
using	NULL
irradiated	NULL
autologous	NULL
PBMC	NULL
and	NULL
antigen	NULL
.	NULL

After	NULL
10	NULL
to	NULL
14	NULL
days	NULL
,	NULL
expanding	NULL
cultures	NULL
were	NULL
transferred	NULL
to	NULL
24-well	NULL
culture	NULL
plates	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

T-cell	NULL
clones	NULL
were	NULL
maintained	NULL
by	NULL
antigenic	NULL
stimulation	NULL
with	NULL
irradiated	NULL
autologous	NULL
PBMC	NULL
(	NULL
2	NULL
x	NULL
and	NULL
rDer	NULL
f	NULL
II	NULL
protein	NULL
every	NULL
2	NULL
to	NULL
3	NULL
weeks	NULL
.	NULL

Stimulation	NULL
of	NULL
T-cell	NULL
clones	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
harvested	NULL
at	NULL
least	NULL
10	NULL
days	NULL
after	NULL
the	NULL
last	NULL
antigenic	NULL
stimulation	NULL
,	NULL
layered	NULL
onto	NULL
Ficoll-Paque	NULL
,	NULL
and	NULL
centrifuged	NULL
.	NULL

The	NULL
interface	NULL
was	NULL
recovered	NULL
,	NULL
washed	NULL
twice	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
fresh	NULL
medium	NULL
.	NULL

The	NULL
resulting	NULL
preparation	NULL
usually	NULL
consisted	NULL
of	NULL
more	NULL
than	NULL
98	NULL
%	NULL
CD3	NULL
*	NULL
cells	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytome-try	NULL
.	NULL

Cells	NULL
(	NULL
10/well	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
triplicate	NULL
with	NULL
various	NULL
stimuli	NULL
in	NULL
96-well	NULL
round-bottom	NULL
culture	NULL
plates	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
and	NULL
then	NULL
supernatants	NULL
were	NULL
harvested	NULL
and	NULL
kept	NULL
frozen	NULL
at	NULL
-70°C	NULL
until	NULL
use	NULL
.	NULL

In	NULL
some	NULL
cultures	NULL
,	NULL
wells	NULL
were	NULL
preincubated	NULL
with	NULL
10	NULL
pg/mL	NULL
anti-CD3	NULL
MoAb	NULL
(	NULL
OKT3	NULL
)	NULL
in	NULL
0.05	NULL
mol/L	NULL
.	NULL

carbonate-bicarbonate	NULL
buffer	NULL
(	NULL
pH	NULL
9.6	NULL
)	NULL
at	NULL
4°C	NULL
overnight	NULL
.	NULL

For	NULL
proliferation	NULL
analysis	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
72	NULL
hours	NULL
.	NULL

*H-Thymidine	NULL
(	NULL
0.5	NULL
mCi/well	NULL
)	NULL
was	NULL
pulsed	NULL
for	NULL
the	NULL
last	NULL
16	NULL
hours	NULL
.	NULL

To	NULL
obtain	NULL
cytoplasmic	NULL
RNA	NULL
,	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
x	NULL
10°/well	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
24-well	NULL
culture	NULL
plates	NULL
with	NULL
various	NULL
stimulants	NULL
for	NULL
the	NULL
designated	NULL
time	NULL
periods	NULL
.	NULL

Quantitation	NULL
of	NULL
cytokines	NULL
.	NULL

IL-5	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
sandwich	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
using	NULL
monoclonal	NULL
antihuman	NULL
IL-5	NULL
(	NULL
D138	NULL
)	NULL
as	NULL
the	NULL
capture	NULL
antibody	NULL
and	NULL
biotinylated	NULL
purified	NULL
rabbit	NULL
antihuman	NULL
IL-5	NULL
as	NULL
the	NULL
second	NULL
antibody	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

The	NULL
linear	NULL
portion	NULL
of	NULL
the	NULL
standard	NULL
curve	NULL
was	NULL
between	NULL
3.9	NULL
and	NULL
500	NULL
pg/mL	NULL
.	NULL

IL-2	NULL
and	NULL
IL-4	NULL
were	NULL
measured	NULL
by	NULL
specific	NULL
ELISA	NULL
(	NULL
Quantikine	NULL
ELISA	NULL
kits	NULL
,	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
.	NULL

Reverse	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
assay	NULL
.	NULL

IL-5	NULL
gene	NULL
expression	NULL
was	NULL
analyzed	NULL
using	NULL
the	NULL
RT-PCR	NULL
method	NULL
as	NULL
reported	NULL
previously	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
the	NULL
pelleted	NULL
cells	NULL
essentially	NULL
following	NULL
the	NULL
one-step	NULL
acid	NULL
guanidinium	NULL
isothiocya-	NULL
MORI	NULL
ET	NULL
AL	NULL
nate/phenol-chloroform	NULL
extraction	NULL
method	NULL
of	NULL
Chomezynski	NULL
and	NULL
Sac-chi	NULL
``	NULL
using	NULL
Isogene	NULL
(	NULL
Nippongene	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

cDNA	NULL
was	NULL
synthesized	NULL
from	NULL
1	NULL
pg	NULL
of	NULL
cytoplasmic	NULL
RNA	NULL
using	NULL
random	NULL
primers	NULL
and	NULL
murine	NULL
Moloney	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
.	NULL

PCRs	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
following	NULL
primers	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
:	NULL
IL-5	NULL
:	NULL
sense	NULL
strand	NULL
primer	NULL
,	NULL
5-GCTTCTGCATITGAG-TITGCTAGCT-3	NULL
'	NULL
,	NULL
and	NULL
antisense	NULL
strand	NULL
primer	NULL
,	NULL
5-TGGCCGTCA-ATGTATTTCTTTATTAAG-3	NULL
'	NULL
;	NULL
B-actin	NULL
:	NULL
sense	NULL
strand	NULL
primer	NULL
,	NULL
5'-ATGGATGATGATATCGCCGCG-3	NULL
'	NULL
,	NULL
and	NULL
antisense	NULL
strand	NULL
primer	NULL
,	NULL
5-CTAGAAGCATTTGCGGTGGACGATGGGGGCC-3	NULL
'	NULL
.	NULL

To	NULL
50	NULL
pL	NULL
(	NULL
final	NULL
volume	NULL
)	NULL
of	NULL
amplification	NULL
solution	NULL
(	NULL
50	NULL
mmol/L	NULL
KCI	NULL
,	NULL
10	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
2	NULL
mmol/L	NULL
MgC1	NULL
;	NULL
,	NULL
0.01	NULL
%	NULL
[	NULL
wt/vol	NULL
]	NULL
gelatin	NULL
,	NULL
0.2	NULL
mmol/L	NULL
of	NULL
each	NULL
deoxynucleotide	NULL
triphosphate	NULL
;	NULL
Toyobo	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
2	NULL
uL	NULL
of	NULL
cDNA	NULL
(	NULL
corresponding	NULL
to	NULL
about	NULL
250	NULL
ng	NULL
of	NULL
starting	NULL
RNA	NULL
material	NULL
)	NULL
,	NULL
0.4	NULL
pmol/L	NULL
of	NULL
each	NULL
primer	NULL
,	NULL
and	NULL
2	NULL
U	NULL
of	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
AmpliTaq	NULL
;	NULL
Perkin	NULL
Elmer	NULL
Cetus	NULL
,	NULL
Norwalk	NULL
,	NULL
CT	NULL
)	NULL
were	NULL
added	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
heated	NULL
at	NULL
95°C	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
followed	NULL
by	NULL
25	NULL
cycles	NULL
,	NULL
each	NULL
consisting	NULL
of	NULL
incubations	NULL
for	NULL
1	NULL
minute	NULL
at	NULL
95°C	NULL
,	NULL
2	NULL
minutes	NULL
at	NULL
60°C	NULL
,	NULL
and	NULL
3	NULL
minutes	NULL
at	NULL
72°C	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ethidium	NULL
bromide	NULL
.	NULL

Plasmid	NULL
constructs	NULL
.	NULL

-	NULL
Human	NULL
genomic	NULL
DNA	NULL
isolated	NULL
from	NULL
HeLa	NULL
cells	NULL
was	NULL
used	NULL
as	NULL
a	NULL
template	NULL
.	NULL

IL-5	NULL
promoter/enhancer	NULL
gene	NULL
(	NULL
-511	NULL
to	NULL
+4	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
)	NULL
was	NULL
PCR	NULL
amplified	NULL
using	NULL
a	NULL
sense	NULL
strand	NULL
primer	NULL
(	NULL
5'-ATACTCGAGGGATCCTAATCA-AGACCC-3	NULL
'	NULL
)	NULL
and	NULL
an	NULL
antisense	NULL
strand	NULL
primer	NULL
(	NULL
5'-TGCAAGCTIT-TGCATAGTACAAGACTGC-3	NULL
``	NULL
)	NULL
according	NULL
to	NULL
the	NULL
DNA	NULL
sequence	NULL
reported	NULL
by	NULL
Tanabe	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
This	NULL
515-bp	NULL
PCR	NULL
product	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
Xho	NULL
I-HindllII	NULL
site	NULL
of	NULL
the	NULL
pGL2	NULL
basic	NULL
vector	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WJ	NULL
)	NULL
to	NULL
construct	NULL
pIL-5	NULL
(	NULL
-511	NULL
)	NULL
Luc	NULL
.	NULL

Identity	NULL
of	NULL
the	NULL
promoter/	NULL
enhancer	NULL
sequence	NULL
with	NULL
the	NULL
originally	NULL
reported	NULL
DNA	NULL
sequence	NULL
was	NULL
confirmed	NULL
by	NULL
chain	NULL
termination	NULL
sequencing	NULL
using	NULL
Sequenase	NULL
2.0	NULL
(	NULL
Strategene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

control	NULL
vector	NULL
(	NULL
Riken	NULL
DNA	NULL
Bank	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
transfection	NULL
control	NULL
.	NULL

Transient	NULL
transfection	NULL
,	NULL
luciferase	NULL
assay	NULL
,	NULL
and	NULL
B-galactosidase	NULL
assay	NULL
.	NULL

T-cell	NULL
clones	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
using	NULL
a	NULL
Gene	NULL
Pulser	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
2.5	NULL
X	NULL
10	NULL
``	NULL
T-cell	NULL
clones	NULL
in	NULL
500	NULL
gL	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
100	NULL
U/mL	NULL
.	NULL

penicillin	NULL
,	NULL
100	NULL
pg/mL	NULL
streptomycin	NULL
,	NULL
and	NULL
10	NULL
U/mL	NULL
rIL-2	NULL
in	NULL
a	NULL
0.4-cm	NULL
electroporation	NULL
cuvette	NULL
were	NULL
incubated	NULL
with	NULL
50	NULL
ug	NULL
of	NULL
pIL-5	NULL
(	NULL
-511	NULL
)	NULL
Luc	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
pCMV-	NULL
$	NULL
-gal	NULL
and	NULL
electro-porated	NULL
at	NULL
270	NULL
V	NULL
,	NULL
960	NULL
uF	NULL
with	NULL
a	NULL
mean	NULL
time	NULL
constant	NULL
of	NULL
19	NULL
millisec-onds	NULL
.	NULL

After	NULL
transfected	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
a	NULL
fresh	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
stimulation	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
assayed	NULL
using	NULL
the	NULL
Luciferase	NULL
Assay	NULL
System	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Relative	NULL
luciferase	NULL
unit	NULL
(	NULL
RLU	NULL
)	NULL
was	NULL
calculated	NULL
by	NULL
the	NULL
following	NULL
formula	NULL
:	NULL
RLU	NULL
=	NULL
Luciferase	NULL
Activity	NULL
in	NULL
Cell	NULL
Lysate/	NULL
Protein	NULL
Content	NULL
(	NULL
in	NULL
milligrams	NULL
per	NULL
milliliter	NULL
)	NULL
.	NULL

B-Galactosidase	NULL
activity	NULL
was	NULL
assayed	NULL
using	NULL
chlorophenol	NULL
(	NULL
CPRG	NULL
)	NULL
as	NULL
the	NULL
substrate	NULL
.	NULL

First	NULL
,	NULL
150	NULL
gL	NULL
of	NULL
cell	NULL
lysates	NULL
diluted	NULL
with	NULL
Z	NULL
buffer	NULL
(	NULL
0.1	NULL
mol/L	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
-NaH	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mmol/L	NULL
KCI	NULL
,	NULL
1	NULL
mmol/L	NULL
MgSO	NULL
,	NULL
50	NULL
mmol/L	NULL
2-mercaptoethanol	NULL
)	NULL
and	NULL
30	NULL
uL	NULL
of	NULL
15	NULL
mmol/L	NULL
CPRG	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
then	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
75	NULL
gL	NULL
of	NULL
1	NULL
mol/L	NULL
Na	NULL
,	NULL
CO	NULL
;	NULL
and	NULL
ODs	NULL
;	NULL
,	NULL
was	NULL
measured	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

-	NULL
Crude	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
cells	NULL
as	NULL
described	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
,	NULL
``	NULL
with	NULL
modifications	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
in	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
suspended	NULL
at	NULL
5	NULL
x	NULL
10'cells/mL	NULL
.	NULL

in	NULL
ice-cold	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mmol/L	NULL
HEPES-KOH	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mmol/	NULL
L	NULL
KCI	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
1	NULL
mmol/L	NULL
dithiothre-itol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
and	NULL
0.5	NULL
mmol/L	NULL
phenylmethyl	NULL
sulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
)	NULL
and	NULL
kept	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

Then	NULL
1/16	NULL
vol	NULL
of	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
vigorously	NULL
vortexed	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
12,000	NULL
rpm	NULL
for	NULL
30	NULL
seconds	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
cytoplasmic	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GC	NULL
EFFECT	NULL
ON	NULL
T-CELL	NULL
IL-5	NULL
GENE	NULL
TRANSCRIPTION	NULL
supernatant	NULL
was	NULL
retained	NULL
on	NULL
ice	NULL
and	NULL
the	NULL
nuclear	NULL
pellet	NULL
was	NULL
washed	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
(	NULL
buffer	NULL
A	NULL
containing	NULL
NP-40	NULL
)	NULL
.	NULL

The	NULL
pellet	NULL
was	NULL
next	NULL
incubated	NULL
with	NULL
3	NULL
vol	NULL
of	NULL
ice-cold	NULL
buffer	NULL
C	NULL
(	NULL
10	NULL
mmol/L	NULL
HEPES-KOH	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
400	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
10	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
1	NULL
mmol/L	NULL
PMSF	NULL
)	NULL
at	NULL
5	NULL
x	NULL
10°	NULL
nuclei/mL	NULL
for	NULL
15	NULL
minutes	NULL
and	NULL
centrifuged	NULL
at	NULL
15,000	NULL
rpm	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
supernatants	NULL
were	NULL
kept	NULL
frozen	NULL
in	NULL
aliquots	NULL
at	NULL
-70°C	NULL
.	NULL

For	NULL
some	NULL
experiments	NULL
,	NULL
they	NULL
were	NULL
dialyzed	NULL
against	NULL
500	NULL
vol	NULL
of	NULL
dialysis	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
HEPES-KOH	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
50	NULL
mmol/L	NULL
NaCI	NULL
,	NULL
50	NULL
%	NULL
glycerol	NULL
[	NULL
vol/vol	NULL
]	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
and	NULL
1	NULL
mmol/	NULL
L	NULL
MgC	NULL
]	NULL
;	NULL
)	NULL
for	NULL
12	NULL
hours	NULL
at	NULL
4°C	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

-	NULL
The	NULL
oligonucleotides	NULL
used	NULL
for	NULL
AP-1	NULL
,	NULL
NF-kB	NULL
and	NULL
Oct-1	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
purchased	NULL
from	NULL
Promega	NULL
:	NULL
AP-1	NULL
(	NULL
5-CGCTTGATGAGTCAGCCG-GAA-3	NULL
'	NULL
)	NULL
,	NULL
``	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
5-AGTTGAGGGGACTTTCCCAGGC-3	NULL
'	NULL
)	NULL
,	NULL
*	NULL
and	NULL
Oct-1	NULL
GAA-3	NULL
'	NULL
)	NULL
.	NULL
``	NULL

NF-AT	NULL
oligonucleotides	NULL
were	NULL
from	NULL
Sawady	NULL
Technology	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
;	NULL
NF-AT	NULL
(	NULL
5-GGAGGAAAAACTGTTTCATACAGAAGGCGT-3	NULL
``	NULL
)	NULL
from	NULL
distal	NULL
NF-AT	NULL
site	NULL
of	NULL
human	NULL
IL-2	NULL
gene	NULL
.	NULL
``	NULL

Pairs	NULL
of	NULL
synthetic	NULL
high-performance	NULL
liquid	NULL
chromatography-purified	NULL
oligonucleotides	NULL
containing	NULL
complementary	NULL
sequences	NULL
were	NULL
annealed	NULL
by	NULL
boiling	NULL
equi-molar	NULL
concentrations	NULL
of	NULL
each	NULL
strand	NULL
for	NULL
10	NULL
minutes	NULL
and	NULL
allowing	NULL
the	NULL
mixture	NULL
to	NULL
slowly	NULL
cool	NULL
in	NULL
a	NULL
water	NULL
bath	NULL
to	NULL
room	NULL
temperature	NULL
.	NULL

Then	NULL
,	NULL
3.5	NULL
pmol	NULL
of	NULL
annealed	NULL
oligonucleotides	NULL
was	NULL
incubated	NULL
in	NULL
a	NULL
10-uL	NULL
reaction	NULL
mixture	NULL
containing	NULL
70	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
10	NULL
mmol/	NULL
L	NULL
MgCl	NULL
;	NULL
,	NULL
5	NULL
mmol/L	NULL
DTT	NULL
,	NULL
and	NULL
10	NULL
gCi	NULL
of	NULL
[	NULL
y-P	NULL
]	NULL
JATP	NULL
(	NULL
3,000	NULL
Ci/	NULL
mmol	NULL
;	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
with	NULL
10	NULL
U	NULL
of	NULL
T4	NULL
poly-nucleotide	NULL
kinase	NULL
(	NULL
Takara	NULL
,	NULL
Otsu	NULL
,	NULL
Japan	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
adding	NULL
1	NULL
L	NULL
of	NULL
0.5	NULL
mol/L	NULL
EDTA	NULL
and	NULL
89	NULL
pL	NULL
TE	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris-HCJ	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
.	NULL

Gel-shift	NULL
analysis	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Gel	NULL
Shift	NULL
Assay	NULL
Systems	NULL
;	NULL
Promega	NULL
)	NULL
with	NULL
slight	NULL
modifications	NULL
.	NULL

Thirty-five	NULL
femtomoles	NULL
of	NULL
P	NULL
end-labeled	NULL
oligonucleotides	NULL
was	NULL
incubated	NULL
in	NULL
a	NULL
10-zL	NULL
reaction	NULL
mixture	NULL
containing	NULL
10	NULL
mmol/L	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
0.5	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.5	NULL
mmol/L	NULL
DTT	NULL
,	NULL
4	NULL
%	NULL
glye-erol	NULL
,	NULL
50	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
,	NULL
and	NULL
0.5	NULL
ug	NULL
poly	NULL
(	NULL
d-dC	NULL
)	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

In	NULL
competition	NULL
experiments	NULL
,	NULL
a	NULL
20	NULL
to	NULL
200	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
,	NULL
relative	NULL
to	NULL
the	NULL
probe	NULL
,	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
bromophenol	NULL
blue	NULL
and	NULL
xylene	NULL
cyanol	NULL
were	NULL
added	NULL
to	NULL
0.02	NULL
%	NULL
and	NULL
the	NULL
resulting	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
acrylamide	NULL
:	NULL
bisacrylamide	NULL
,	NULL
30:1	NULL
wt/wt	NULL
)	NULL
by	NULL
electrophoresis	NULL
at	NULL
100	NULL
V	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
TBE	NULL
:	NULL
89	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
89	NULL
mmol/L	NULL
boric	NULL
acid	NULL
,	NULL
and	NULL
2	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
subsequently	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
RX	NULL
film	NULL
(	NULL
Fuji	NULL
Photo	NULL
Film	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
at	NULL
-70°C	NULL
.	NULL

Protein	NULL
assay	NULL
.	NULL

-	NULL
Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
using	NULL
bicinchoninic	NULL
acid	NULL
protein	NULL
assay	NULL
reagent	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
.	NULL

Statistical	NULL
analysis	NULL
.	NULL

-	NULL
Statistical	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
Student	NULL
's	NULL
t-test	NULL
.	NULL

A	NULL
value	NULL
of	NULL
P	NULL
<	NULL
.05	NULL
was	NULL
considered	NULL
to	NULL
be	NULL
statistically	NULL
significant	NULL
.	NULL

Responses	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
(	NULL
SEM	NULL
)	NULL
.	NULL

RESULTS	NULL
GC	NULL
suppressed	NULL
cytokine	NULL
production	NULL
of	NULL
human	NULL
T-cell	NULL
clones	NULL
stimulated	NULL
via	NULL
T-cell	NULL
receptor	NULL
complex	NULL
.	NULL

The	NULL
first	NULL
experiment	NULL
was	NULL
performed	NULL
to	NULL
test	NULL
whether	NULL
IL-5	NULL
production	NULL
of	NULL
human	NULL
helper	NULL
T-cell	NULL
clones	NULL
is	NULL
suppressed	NULL
by	NULL
GC	NULL
.	NULL

T-cell	NULL
clones	NULL
were	NULL
used	NULL
for	NULL
experiments	NULL
at	NULL
least	NULL
10	NULL
days	NULL
after	NULL
the	NULL
last	NULL
antigenic	NULL
stimulation	NULL
.	NULL

As	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
T	NULL
cells	NULL
obtained	NULL
from	NULL
the	NULL
interface	NULL
of	NULL
Ficoll-Paque	NULL
density	NULL
gradient	NULL
consisted	NULL
of	NULL
more	NULL
than	NULL
98	NULL
%	NULL
pure	NULL
CD3¢*	NULL
2893	NULL
CD4*	NULL
cells	NULL
.	NULL

They	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
,	NULL
resuspended	NULL
in	NULL
fresh	NULL
medium	NULL
,	NULL
and	NULL
stimulated	NULL
via	NULL
T-cell	NULL
receptor	NULL
using	NULL
immobilized	NULL
anti-CD3	NULL
MoAb	NULL
.	NULL

Culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
after	NULL
24	NULL
hours	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
,	NULL
all	NULL
of	NULL
the	NULL
three	NULL
agents	NULL
,	NULL
hydrocortisone	NULL
(	NULL
A	NULL
)	NULL
,	NULL
prednisolone	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
dexamethasone	NULL
(	NULL
C	NULL
)	NULL
,	NULL
suppressed	NULL
the	NULL
production	NULL
of	NULL
IL-5	NULL
by	NULL
activated	NULL
T-cell	NULL
clones	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

The	NULL
concentrations	NULL
of	NULL
each	NULL
agent	NULL
required	NULL
for	NULL
half	NULL
maximal	NULL
inhibition	NULL
(	NULL
IC	NULL
,	NULL
)	NULL
were	NULL
~100	NULL
nmol/L	NULL
,	NULL
~20	NULL
nmol/L	NULL
,	NULL
and	NULL
~1	NULL
nmol/L	NULL
,	NULL
respectively	NULL
.	NULL

All	NULL
three	NULL
agents	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
viability	NULL
of	NULL
cells	NULL
after	NULL
24	NULL
hours	NULL
of	NULL
incubation	NULL
at	NULL
the	NULL
concentrations	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
,	NULL
thereby	NULL
excluding	NULL
nonspecific	NULL
toxicity	NULL
of	NULL
the	NULL
agents	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
results	NULL
clearly	NULL
indicate	NULL
that	NULL
GC	NULL
directly	NULL
act	NULL
on	NULL
T	NULL
cells	NULL
to	NULL
suppress	NULL
IL-5	NULL
synthesis	NULL
.	NULL

Dexamethasone	NULL
suppressed	NULL
IL-5	NULL
production	NULL
induced	NULL
by	NULL
IL-2	NULL
.	NULL

_	NULL
We	NULL
have	NULL
recently	NULL
reported	NULL
that	NULL
T-cell	NULL
clones	NULL
that	NULL
produce	NULL
IL-5	NULL
upon	NULL
antigenic	NULL
stimulation	NULL
also	NULL
produce	NULL
IL-5	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
and	NULL
that	NULL
IL-5	NULL
production	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
is	NULL
dependent	NULL
on	NULL
IL-2	NULL
.	NULL
``	NULL

PI	NULL
turnover	NULL
,	NULL
PKC	NULL
activation	NULL
,	NULL
and	NULL
Ca**	NULL
influx	NULL
were	NULL
not	NULL
observed	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-2	NULL
,	NULL
``	NULL
**	NULL
although	NULL
these	NULL
early	NULL
biochemical	NULL
events	NULL
are	NULL
the	NULL
hallmarks	NULL
of	NULL
TCR-mediated	NULL
T-cell	NULL
activation	NULL
.	NULL
``	NULL

TCR-induced	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
is	NULL
inhibited	NULL
by	NULL
FK506	NULL
,	NULL
but	NULL
IL-2-induced	NULL
proliferation	NULL
is	NULL
not	NULL
.	NULL
``	NULL

''	NULL
Therefore	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
GC	NULL
on	NULL
IL-2-induced	NULL
IL-5	NULL
production	NULL
were	NULL
next	NULL
examined	NULL
.	NULL

T-cell	NULL
clones	NULL
HKS	NULL
,	NULL
YA5	NULL
,	NULL
HK2	NULL
,	NULL
and	NULL
YAS	NULL
were	NULL
stimulated	NULL
by	NULL
recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
100	NULL
U/mL	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
dexamethasone	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
2	NULL
,	NULL
dexamethasone	NULL
clearly	NULL
suppressed	NULL
IL-5	NULL
production	NULL
(	NULL
A	NULL
)	NULL
and	NULL
proliferation	NULL
(	NULL
B	NULL
)	NULL
of	NULL
these	NULL
T-cell	NULL
clones	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
indicating	NULL
that	NULL
IL-2	NULL
signals	NULL
leading	NULL
to	NULL
cytokine	NULL
production	NULL
and	NULL
proliferation	NULL
of	NULL
helper	NULL
T	NULL
cells	NULL
are	NULL
both	NULL
sensitive	NULL
to	NULL
GC	NULL
.	NULL

Essentially	NULL
the	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
five	NULL
other	NULL
T-cell	NULL
clones	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
observation	NULL
was	NULL
not	NULL
restricted	NULL
to	NULL
these	NULL
particular	NULL
clones	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-2-induced	NULL
proliferation	NULL
of	NULL
CTLL-2	NULL
cells	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
dexamethasone	NULL
.	NULL

-	NULL
Because	NULL
dexamethasone-resistant	NULL
proliferation	NULL
of	NULL
murine	NULL
CD8*	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-2	NULL
was	NULL
reported	NULL
by	NULL
previous	NULL
investigators	NULL
,	NULL
``	NULL
``	NULL
we	NULL
confirmed	NULL
the	NULL
inability	NULL
of	NULL
dexamethasone	NULL
to	NULL
suppress	NULL
IL-2-induced	NULL
proliferation	NULL
employing	NULL
a	NULL
murine	NULL
cytotoxic	NULL
T-cell	NULL
line	NULL
,	NULL
CTLL-2	NULL
,	NULL
which	NULL
is	NULL
a	NULL
well-characterized	NULL
IL-2-dependent	NULL
cell	NULL
line	NULL
commonly	NULL
used	NULL
for	NULL
the	NULL
bioassay	NULL
of	NULL
human	NULL
IL-2	NULL
,	NULL
murine	NULL
IL-2	NULL
,	NULL
and	NULL
murine	NULL
IL-4	NULL
.	NULL
``	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
3	NULL
,	NULL
CTLL-2	NULL
cells	NULL
proliferated	NULL
in	NULL
response	NULL
to	NULL
exogenous	NULL
rIL-2	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Dexamethasone	NULL
at	NULL
concentrations	NULL
of	NULL
100	NULL
nmol/L	NULL
and	NULL
1	NULL
pmol/	NULL
L	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
proliferative	NULL
response	NULL
of	NULL
CTLL-2	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
IL-2R	NULL
signal	NULL
leading	NULL
to	NULL
the	NULL
proliferation	NULL
of	NULL
CD8*	NULL
(	NULL
cytotoxic	NULL
)	NULL
T	NULL
cells	NULL
is	NULL
transduced	NULL
by	NULL
GC-resistant	NULL
signaling	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
IL-2R	NULL
signal	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Dexamethasone	NULL
suppressed	NULL
IL-5	NULL
gene	NULL
expressions	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
dexamethasone	NULL
on	NULL
IL-5	NULL
gene	NULL
expression	NULL
using	NULL
RT-PCR	NULL
analysis	NULL
.	NULL

T-cell	NULL
clone	NULL
(	NULL
Y¥AS	NULL
)	NULL
was	NULL
stimulated	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
MoAb	NULL
or	NULL
rIL-2	NULL
(	NULL
100	NULL
U/mL	NULL
)	NULL
for	NULL
the	NULL
designated	NULL
time	NULL
periods	NULL
and	NULL
total	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
extracted	NULL
.	NULL

RNA	NULL
was	NULL
then	NULL
reverse	NULL
transcribed	NULL
and	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
primer	NULL
sets	NULL
specific	NULL
for	NULL
human	NULL
IL-5	NULL
and	NULL
B-actin	NULL
.	NULL

The	NULL
number	NULL
of	NULL
cycles	NULL
was	NULL
titrated	NULL
before	NULL
the	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2894	NULL
A	NULL
2000	NULL
E	NULL
1500	NULL
8	NULL
+	NULL
é	NULL
*	NULL
seee	NULL
,	NULL
=	NULL
0	NULL
*	NULL
=	NULL
1000-	NULL
A	NULL
3	NULL
A\	NULL
6	NULL
\	NULL
a.	NULL
u	NULL
a	NULL
500	NULL
c	NULL
U	NULL
U	NULL
¥	NULL
‘	NULL
h	NULL
0	NULL
10	NULL
102	NULL
0	NULL
ao	NULL
10+	NULL
Hydrocortisone	NULL
(	NULL
nM	NULL
)	NULL
B	NULL
2000	NULL
€	NULL
1500-	NULL
&	NULL
B	NULL
{	NULL
____	NULL
{	NULL
\	NULL
5	NULL
\	NULL
5	NULL
10004	NULL
\	NULL
a	NULL
0	NULL
a	NULL
u	NULL
3	NULL
5004	NULL
0	NULL
0	NULL
10	NULL
10°	NULL
-	NULL
aot	NULL
Prednisolone	NULL
(	NULL
nM	NULL
)	NULL
experiment	NULL
and	NULL
reactions	NULL
were	NULL
repeated	NULL
for	NULL
25	NULL
cycles	NULL
,	NULL
because	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
amplified	NULL
exponentially	NULL
between	NULL
23	NULL
and	NULL
30	NULL
cycles	NULL
.	NULL

IL-5	NULL
mRNA	NULL
was	NULL
induced	NULL
in	NULL
T-cell	NULL
clones	NULL
stimulated	NULL
with	NULL
either	NULL
immobilized	NULL
anti-CD3	NULL
antibody	NULL
or	NULL
rIL-2	NULL
and	NULL
reached	NULL
maximum	NULL
after	NULL
6	NULL
to	NULL
9	NULL
hours	NULL
,	NULL
as	NULL
reported	NULL
previously	NULL
.	NULL
``	NULL

A	NULL
representative	NULL
result	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
4	NULL
.	NULL

IL-5	NULL
mRNA	NULL
induced	NULL
by	NULL
either	NULL
stimulus	NULL
was	NULL
totally	NULL
downregulated	NULL
by	NULL
dexamethasone	NULL
.	NULL

Essentially	NULL
the	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
PCR	NULL
was	NULL
performed	NULL
for	NULL
23	NULL
and	NULL
27	NULL
cycles	NULL
,	NULL
because	NULL
the	NULL
PCR	NULL
reaction	NULL
was	NULL
linear	NULL
between	NULL
23	NULL
and	NULL
30	NULL
cycles	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
amounts	NULL
of	NULL
PCR	NULL
products	NULL
at	NULL
25	NULL
cycles	NULL
well	NULL
reflect	NULL
the	NULL
relative	NULL
quantity	NULL
of	NULL
mRNA	NULL
in	NULL
the	NULL
original	NULL
RNA	NULL
preparations	NULL
.	NULL

Dexamethasone	NULL
suppressed	NULL
the	NULL
transcriptional	NULL
activity	NULL
mediated	NULL
by	NULL
~500-bp	NULL
human	NULL
IL-5	NULL
promoter/enhancer	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
dexamethasone	NULL
inhibits	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
transcription	NULL
mainly	NULL
by	NULL
interfering	NULL
with	NULL
AP-1	NULL
MORI	NULL
ET	NULL
AL	NULL
IL-5	NULL
production	NULL
(	NULL
pg/ml	NULL
)	NULL
00	NULL
of	NULL
400	NULL
100	NULL
1000	NULL
Dexamethasone	NULL
(	NULL
nM	NULL
)	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
TCR-induced	NULL
IL-5	NULL
production	NULL
was	NULL
suppressed	NULL
by	NULL
glucocorticoids	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10°	NULL
T-cell	NULL
clones	NULL
(	NULL
[	NULL
O	NULL
]	NULL
HKS	NULL
;	NULL
[	NULL
A	NULL
]	NULL
YAS	NULL
;	NULL
[	NULL
C	NULL
]	NULL
HK2	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
96-well	NULL
round-bottom	NULL
culture	NULL
plates	NULL
pretreated	NULL
with	NULL
OKT3	NULL
MoAb	NULL
(	NULL
10	NULL
mg/mL	NULL
)	NULL
.	NULL

Designated	NULL
concentrations	NULL
of	NULL
hydrocortisone	NULL
(	NULL
A	NULL
)	NULL
,	NULL
prednisolone	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
dexamethasone	NULL
(	NULL
C	NULL
)	NULL
were	NULL
included	NULL
from	NULL
the	NULL
start	NULL
of	NULL
some	NULL
cultures	NULL
.	NULL

Culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
after	NULL
24	NULL
hours	NULL
and	NULL
assayed	NULL
for	NULL
IL-5	NULL
by	NULL
a	NULL
specific	NULL
ELISA	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
cultures	NULL
+	NULL
SEM	NULL
.	NULL

IL-5	NULL
production	NULL
in	NULL
the	NULL
unstimulated	NULL
cultures	NULL
was	NULL
always	NULL
below	NULL
the	NULL
detection	NULL
limit	NULL
of	NULL
the	NULL
ELISA	NULL
system	NULL
(	NULL
<	NULL
1	NULL
pg/mL	NULL
)	NULL
.	NULL

activity	NULL
.	NULL
``	NULL

''	NULL
We	NULL
used	NULL
a	NULL
transient	NULL
transfection	NULL
system	NULL
to	NULL
analyze	NULL
whether	NULL
dexamethasone	NULL
suppresses	NULL
human	NULL
IL-5	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
511-bp	NULL
human	NULL
IL-5	NULL
promoter/enhancer-luciferase	NULL
gene	NULL
construct	NULL
,	NULL
pIL-5	NULL
(	NULL
-511	NULL
)	NULL
Luc	NULL
,	NULL
was	NULL
transiently	NULL
transfected	NULL
to	NULL
T-cell	NULL
clones	NULL
by	NULL
electroporation	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
MoAb	NULL
or	NULL
IL-2	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
luciferase	NULL
activity	NULL
was	NULL
induced	NULL
upon	NULL
stimulation	NULL
and	NULL
was	NULL
clearly	NULL
downregulated	NULL
by	NULL
dexamethasone	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
GC	NULL
on	NULL
IL-5	NULL
synthesis	NULL
is	NULL
exerted	NULL
at	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

B-Galactosidase	NULL
activity	NULL
derived	NULL
from	NULL
pCMV	NULL
--	NULL
gal	NULL
,	NULL
a	NULL
transfection	NULL
control	NULL
,	NULL
did	NULL
not	NULL
differ	NULL
significantly	NULL
either	NULL
between	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
cells	NULL
or	NULL
between	NULL
GC	NULL
-treated	NULL
and	NULL
GC-nontreated	NULL
cells	NULL
.	NULL

GC-sensitive	NULL
transcription	NULL
of	NULL
pIL-5Luc	NULL
was	NULL
confirmed	NULL
in	NULL
two	NULL
other	NULL
T-cell	NULL
clones	NULL
(	NULL
HK2	NULL
and	NULL
HK5	NULL
)	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
dexamethasone-treated	NULL
T-cell	NULL
clones	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GC	NULL
EFFECT	NULL
ON	NULL
T-CELL	NULL
IL-5	NULL
GENE	NULL
TRANSCRIPTION	NULL
The	NULL
findings	NULL
given	NULL
above	NULL
that	NULL
both	NULL
activation	NULL
signals	NULL
mediated	NULL
through	NULL
TCR-	NULL
and	NULL
IL-2R-induced	NULL
GC-sensitive	NULL
gene	NULL
transcription	NULL
and	NULL
protein	NULL
synthesis	NULL
of	NULL
IL-5	NULL
prompted	NULL
us	NULL
to	NULL
examine	NULL
whether	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
GC-sensitive	NULL
transcription	NULL
factors	NULL
,	NULL
were	NULL
induced	NULL
by	NULL
either	NULL
TCR	NULL
or	NULL
IL-2R	NULL
stimula-	NULL
40004	NULL
3000-4	NULL
2000-4	NULL
10004	NULL
IL-5	NULL
production	NULL
(	NULL
pg/m	NULL
!	NULL
)	NULL

0	NULL
0.1	NULL
1	NULL
10	NULL
100	NULL
Dexamethasone	NULL
(	NULL
nM	NULL
)	NULL
70	NULL
607	NULL
50	NULL
~	NULL
+	NULL
404	NULL
to	NULL
anf	NULL
=	NULL
ek	NULL
.	NULL

®	NULL
.	NULL

*s	NULL
*	NULL
A	NULL
204	NULL
i	NULL
\	NULL
§.___§-___	NULL
ﬁr~lu	NULL
*	NULL
~*	NULL
.	NULL

3H-Thymidine	NULL
incorporation	NULL
(	NULL
x10	NULL
)	NULL
104	NULL
``	NULL
S	NULL
*	NULL
%	NULL
SB	NULL
6	NULL
0	NULL
L	NULL
U	NULL
-Q	NULL
.	NULL

0	NULL
0.1	NULL
1	NULL
10	NULL
100	NULL
Dexamethasone	NULL
(	NULL
nM	NULL
)	NULL
Fig	NULL
2	NULL
.	NULL

IL-2-induced	NULL
IL-5	NULL
production	NULL
and	NULL
proliferation	NULL
of	NULL
T-cell	NULL
clones	NULL
were	NULL
suppressed	NULL
by	NULL
dexamethasone	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
total	NULL
of	NULL
10°	NULL
T-cell	NULL
clones	NULL
(	NULL
[	NULL
O	NULL
]	NULL
HKS	NULL
;	NULL
[	NULL
A	NULL
]	NULL
YA5	NULL
;	NULL
[	NULL
D	NULL
]	NULL
HK2	NULL
;	NULL
[	NULL
@	NULL
]	NULL
YA8	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
96-well	NULL
round-bottom	NULL
culture	NULL
plates	NULL
with	NULL
human	NULL
rIL-2	NULL
(	NULL
100	NULL
U/mL	NULL
)	NULL
.	NULL

Designated	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
were	NULL
included	NULL
from	NULL
the	NULL
start	NULL
of	NULL
some	NULL
cultures	NULL
.	NULL

Culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
after	NULL
24	NULL
hours	NULL
and	NULL
assayed	NULL
for	NULL
IL-5	NULL
by	NULL
a	NULL
specific	NULL
ELISA	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
cultures	NULL
+	NULL
SEM	NULL
.	NULL

IL-5	NULL
production	NULL
in	NULL
the	NULL
unstimulated	NULL
cultures	NULL
was	NULL
always	NULL
below	NULL
the	NULL
detection	NULL
limit	NULL
of	NULL
the	NULL
ELISA	NULL
system	NULL
(	NULL
<	NULL
1	NULL
pg/mL	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
For	NULL
proliferation	NULL
assays	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
72	NULL
hours	NULL
.	NULL

°H-Thymidine	NULL
(	NULL
0.5	NULL
pCi/well	NULL
)	NULL
was	NULL
pulsed	NULL
for	NULL
the	NULL
last	NULL
16	NULL
hours	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
cultures	NULL
+	NULL
SEM	NULL
.	NULL

*H-Thymidine	NULL
incorporation	NULL
of	NULL
unstimulated	NULL
HK5	NULL
,	NULL
YA5	NULL
,	NULL
HK2	NULL
,	NULL
and	NULL
YAS	NULL
cells	NULL
was	NULL
362	NULL
+	NULL
154	NULL
,	NULL
526	NULL
+	NULL
193	NULL
,	NULL
759	NULL
+	NULL
227	NULL
,	NULL
and	NULL
668	NULL
+	NULL
149	NULL
,	NULL
respectively	NULL
.	NULL

2895	NULL
-	NULL
40	NULL
C	NULL
O	NULL
x	NULL
3	NULL
so-C	NULL
6	NULL
2	NULL
8	NULL
20+	NULL
=	NULL
®	NULL
.E	NULL
3	NULL
g	NULL
10	NULL
4	NULL
--	NULL
o0-	NULL
Control	NULL
f=	NULL
-A-	NULL
Dex	NULL
100	NULL
nM	NULL
fs	NULL
-O-	NULL
Dex	NULL
1	NULL
uM	NULL
C	NULL
0	NULL
U	NULL
U	NULL
U	NULL
0	NULL
iB	NULL
4/2000	NULL
200	NULL
800	NULL
320	NULL
128	NULL
rIL-2	NULL
(	NULL
U/ml	NULL
)	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
IL-2-induced	NULL
proliferation	NULL
of	NULL
CTLL-2	NULL
cells	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
dexamethasone	NULL
.	NULL

CTLL-2	NULL
cells	NULL
(	NULL
10'/well	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
designated	NULL
concentrations	NULL
of	NULL
rIL-2	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

Either	NULL
100	NULL
nmol/L	NULL
or	NULL
1	NULL
pmol/L	NULL
dexamethasone	NULL
was	NULL
included	NULL
from	NULL
the	NULL
start	NULL
of	NULL
some	NULL
cultures	NULL
.	NULL

°H-Thymidine	NULL
(	NULL
0.5	NULL
pCi/well	NULL
)	NULL
was	NULL
pulsed	NULL
for	NULL
the	NULL
last	NULL
6	NULL
hours	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
cultures	NULL
+	NULL
SEM	NULL
.	NULL

tion	NULL
and	NULL
were	NULL
downregulated	NULL
by	NULL
dexamethasone	NULL
.	NULL

Representative	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
5	NULL
.	NULL

Each	NULL
band	NULL
indicated	NULL
by	NULL
the	NULL
arrowhead	NULL
shows	NULL
the	NULL
specific	NULL
binding	NULL
that	NULL
was	NULL
diminished	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
excess	NULL
amounts	NULL
of	NULL
unlabeled	NULL
probes	NULL
in	NULL
the	NULL
preliminary	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NF-AT	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activities	NULL
were	NULL
clearly	NULL
upregulated	NULL
in	NULL
the	NULL
nuclear	NULL
protein	NULL
preparations	NULL
upon	NULL
stimulation	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
MoAb	NULL
.	NULL

Oct-1	NULL
binding	NULL
activities	NULL
were	NULL
consti-tutively	NULL
present	NULL
in	NULL
the	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
nuclear	NULL
proteins	NULL
and	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
dexamethasone	NULL
.	NULL

AP-1	NULL
and	NULL
NF-kB	NULL
binding	NULL
activities	NULL
were	NULL
clearly	NULL
downregulated	NULL
by	NULL
dexamethasone	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
transcription	NULL
factors	NULL
are	NULL
the	NULL
targets	NULL
of	NULL
GC	NULL
action	NULL
on	NULL
IL-5	NULL
synthesis	NULL
.	NULL

NF-AT	NULL
binding	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
dexamethasone	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
TCR	NULL
stimulation	NULL
,	NULL
neither	NULL
NF-AT	NULL
nor	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
significantly	NULL
induced	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
IL-2-stimulated	NULL
T	NULL
cells	NULL
.	NULL

Essentially	NULL
the	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
three	NULL
other	NULL
T-cell	NULL
clones	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
AP-1	NULL
and	NULL
NF-AT	NULL
are	NULL
critical	NULL
transcription	NULL
factors	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
,	NULL
``	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
IL-5	NULL
gene	NULL
transcription	NULL
using	NULL
human	NULL
helper	NULL
T	NULL
cells	NULL
may	NULL
occur	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
apparent	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NF-AT	NULL
and	NULL
still	NULL
in	NULL
a	NULL
manner	NULL
sensitive	NULL
to	NULL
GC	NULL
.	NULL

DISCUSSION	NULL
In	NULL
our	NULL
present	NULL
study	NULL
,	NULL
allergen-specific	NULL
human	NULL
T-cell	NULL
clones	NULL
established	NULL
from	NULL
atopic	NULL
asthmatic	NULL
donors	NULL
were	NULL
used	NULL
to	NULL
delineate	NULL
the	NULL
action	NULL
of	NULL
GC	NULL
on	NULL
IL-5	NULL
synthesis	NULL
.	NULL

It	NULL
was	NULL
clearly	NULL
shown	NULL
that	NULL
IL-5	NULL
synthesis	NULL
of	NULL
human	NULL
helper	NULL
T	NULL
cells	NULL
induced	NULL
by	NULL
two	NULL
distinct	NULL
stimuli	NULL
mediated	NULL
through	NULL
TCR	NULL
and	NULL
IL-2R	NULL
was	NULL
completely	NULL
suppressed	NULL
by	NULL
GC	NULL
(	NULL
Figs	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

IL-5	NULL
mRNA	NULL
expression	NULL
induced	NULL
by	NULL
either	NULL
stimulus	NULL
was	NULL
clearly	NULL
downregulated	NULL
by	NULL
dexamethasone	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Dexamethasone	NULL
suppressed	NULL
the	NULL
transcriptional	NULL
activity	NULL
mediated	NULL
through	NULL
the	NULL
~500-bp	NULL
hu-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2896	NULL
MORI	NULL
ET	NULL
AL	NULL
A	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
0	NULL
_-	NULL
4	NULL
8	NULL
16	NULL
Stimulation	NULL
'	NULL
IL-2	NULL
«	NULL
CD3	NULL
IL-2	NULL
``	NULL
«	NULL
CD3	NULL
IL-2	NULL
Dexamethasone	NULL
-	NULL
-	NULL
4+	NULL
-	NULL
O+	NULL
-	NULL
#	NULL
-	NULL
$	NULL
-	NULL
-	NULL
+	NULL
-actin	NULL
Fig	NULL
4	NULL
.	NULL

Dexamethasone	NULL
suppressed	NULL
IL-5	NULL
gene	NULL
expression	NULL
of	NULL
human	NULL
T-cell	NULL
clones	NULL
stimulated	NULL
via	NULL
TCR	NULL
and	NULL
IL-2R	NULL
.	NULL

(	NULL
A	NULL
)	NULL
T-cell	NULL
clone	NULL
(	NULL
YA5	NULL
,	NULL
2	NULL
x	NULL
10°/well	NULL
)	NULL
was	NULL
cultured	NULL
in	NULL
24-well	NULL
culture	NULL
plates	NULL
for	NULL
the	NULL
designated	NULL
time	NULL
periods	NULL
.	NULL

B	NULL
Some	NULL
wells	NULL
were	NULL
pretreated	NULL
with	NULL
OKT3	NULL
MoAb	NULL
(	NULL
10	NULL
pg/mL	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

rIL-2	NULL
(	NULL
100	NULL
U/mL	NULL
)	NULL
was	NULL
IL-5	NULL
CIone	NULL
HK2	NULL
HK5	NULL
added	NULL
to	NULL
the	NULL
designated	NULL
wells	NULL
.	NULL

&	NULL
&	NULL
F	NULL
1	NULL
F	NULL
¥	NULL
Dexamethasone	NULL
(	NULL
100	NULL
nmol/L	NULL
)	NULL
Stimulation	NULL
-	NULL
_-	NULL
aCD3	NULL
IL-2	NULL
-	NULL
_-	NULL
aCD3	NULL
-	NULL
IL-2	NULL
was	NULL
included	NULL
throughout	NULL
the	NULL
culture	NULL
period	NULL
in	NULL
some	NULL
wells	NULL
,	NULL
as	NULL
Dexameth	NULL
asone	NULL
=	NULL
=	NULL
4	NULL
-	NULL
4	NULL
=	NULL
=	NULL
s	NULL
=	NULL
4	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
after	NULL
0	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
16	NULL
hours	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
then	NULL
extracted	NULL
,	NULL
reverse	NULL
i	NULL
transcribed	NULL
,	NULL
and	NULL
amplified	NULL
by	NULL
ﬁ-aCtl	NULL
n	NULL
_	NULL
_	NULL
PCR	NULL
.	NULL

The	NULL
279-	NULL
and	NULL
1,128-bp	NULL
Pl	NULL
‘	NULL
Od-ucts	NULL
correspond	NULL
with	NULL
the	NULL
ex	NULL
pected	NULL
size	NULL
of	NULL
IL-5	NULL
and	NULL
B-actin	NULL
amplification	NULL
products	NULL
,	NULL
respec-	NULL
tively	NULL
.	NULL

(	NULL
B	NULL
)	NULL
T-cell	NULL
clone	NULL
(	NULL
HK2	NULL
and	NULL
HK5	NULL
)	NULL
was	NULL
stimulated	NULL
for	NULL
8	NULL
hours	NULL
.	NULL

IL-5	NULL
man	NULL
IL-5	NULL
promoter/enhancer	NULL
gene	NULL
segment	NULL
located	NULL
5	NULL
'	NULL
up-	NULL
It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
GC	NULL
inhibit	NULL
the	NULL
production	NULL
of	NULL
various	NULL
stream	NULL
of	NULL
the	NULL
coding	NULL
region	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
interferon-y	NULL
,	NULL
and	NULL
inhibition	NULL
of	NULL
IL-5	NULL
synthesis	NULL
by	NULL
GC	NULL
was	NULL
exerted	NULL
at	NULL
the	NULL
level	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL
``	NULL

''	NULL
The	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

mechanisms	NULL
of	NULL
action	NULL
of	NULL
GC	NULL
have	NULL
been	NULL
elucidated	NULL
since	NULL
the	NULL
Table	NULL
1	NULL
.	NULL

Dexamethasone	NULL
Suppressed	NULL
Human	NULL
IL-5	NULL
Promoter/Enhancer	NULL
Activity	NULL
Induced	NULL
by	NULL
Either	NULL
TCR	NULL
or	NULL
IL-2R	NULL
Stimulation	NULL
Clone*	NULL
Stimulationt	NULL
Dext	NULL
Luciferase	NULL
Activity§	NULL
(	NULL
per	NULL
ug	NULL
protein	NULL
}	NULL
-Galactosidase	NULL
Activity§	NULL
(	NULL
per	NULL
pg	NULL
protein	NULL
}	NULL
YA5	NULL
None	NULL
-	NULL
10.9	NULL
+	NULL
1.0	NULL
0.67	NULL
+	NULL
0.07	NULL
Anti-CD3	NULL
-	NULL
192.4	NULL
+	NULL
12.2	NULL
0.59	NULL
+	NULL
0.08	NULL
+	NULL
21.0	NULL
+	NULL
2.0	NULL
0.62	NULL
+	NULL
0.07	NULL
IL-2	NULL
-	NULL
118.2	NULL
+	NULL
10.0	NULL
0.66	NULL
+	NULL
0.08	NULL
+	NULL
17.2	NULL
+	NULL
1.2	NULL
0.69	NULL
+	NULL
0.06	NULL
HKS	NULL
None	NULL
-	NULL
4.2	NULL
+	NULL
1.0	NULL
0.92	NULL
+	NULL
0.08	NULL
Anti-CD3	NULL
-	NULL
479.2	NULL
+	NULL
30.9	NULL
0.87	NULL
+	NULL
0.10	NULL
+	NULL
12.3	NULL
+	NULL
1.0	NULL
0.97	NULL
+	NULL
0.13	NULL
HK2	NULL
None	NULL
-	NULL
8.2	NULL
+	NULL
1.0	NULL
0.72	NULL
+	NULL
0.08	NULL
IL-2	NULL
-	NULL
269.2	NULL
+	NULL
20.1	NULL
0.67	NULL
+	NULL
0.11	NULL
+	NULL
9.2	NULL
+	NULL
2.9	NULL
0.77	NULL
+	NULL
0.10	NULL
*	NULL
IL-5-producing	NULL
T-cell	NULL
clones	NULL
(	NULL
2.5	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
in	NULL
500	NULL
mL	NULL
RPMI1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
and	NULL
10	NULL
U/mL	NULL
rIL-2	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
pIL-5Luc	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
+	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
by	NULL
electroporation	NULL
(	NULL
270	NULL
V	NULL
,	NULL
960	NULL
LF	NULL
)	NULL
using	NULL
a	NULL
0.4-cm	NULL
cuvette	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
a	NULL
fresh	NULL
medium	NULL
and	NULL
cultured	NULL
in	NULL
triplicate	NULL
in	NULL
24-well	NULL
culture	NULL
plates	NULL
.	NULL

t	NULL
Cells	NULL
were	NULL
either	NULL
stimulated	NULL
with	NULL
rIL-2	NULL
(	NULL
100	NULL
U/mL	NULL
)	NULL
or	NULL
immobilized	NULL
anti-CD3	NULL
MoAb	NULL
or	NULL
kept	NULL
unstimulated	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

+	NULL
Dexamethasone	NULL
(	NULL
1	NULL
pmol/L	NULL
)	NULL
was	NULL
included	NULL
from	NULL
the	NULL
start	NULL
of	NULL
some	NULL
cultures	NULL
,	NULL
as	NULL
indicated..	NULL
§	NULL
After	NULL
24	NULL
hours	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
tested	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
Luciferase	NULL
Assay	NULL
System	NULL
and	NULL
A-galactosidase	NULL
activity	NULL
using	NULL
CPRG	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
with	NULL
bicinchoninic	NULL
acid	NULL
protein	NULL
assay	NULL
reagent	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
cultures	NULL
+	NULL
SEM	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GC	NULL
EFFECT	NULL
ON	NULL
T-CELL	NULL
IL-5	NULL
GENE	NULL
TRANSCRIPTION	NULL
Stimulus	NULL
-	NULL
|	NULL
aCD3	NULL
IL-2	NULL
Dex	NULL
-	NULL
|	NULL
-	NULL
4	NULL
%	NULL
|	NULL
-	NULL
+	NULL
#	NULL
A	NULL
)	NULL
NF-AT	NULL
AMM	NULL
!	NULL

:	NULL
b	NULL
3	NULL
B	NULL
)	NULL
AP-1	NULL
‘	NULL
—	NULL
``	NULL
``	NULL
``	NULL
pe	NULL
C	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
W	NULL
tos	NULL
>	NULL
=	NULL
<	NULL
D	NULL
)	NULL
Oct-1	NULL
~f	NULL
:	NULL
Fig	NULL
5	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
dexamethasone	NULL
on	NULL
NF-AT	NULL
,	NULL
AP-1	NULL
,	NULL
NF-B	NULL
,	NULL
and	NULL
Oct-1	NULL
binding	NULL
activities	NULL
.	NULL

T-cell	NULL
clones	NULL
(	NULL
YA5	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
MoAb	NULL
or	NULL
rIL-2	NULL
(	NULL
100	NULL
U/mL	NULL
)	NULL
for	NULL
2	NULL
hours	NULL
.	NULL

Dexamethasone	NULL
{	NULL
1	NULL
pmol/L	NULL
)	NULL
was	NULL
added	NULL
to	NULL
some	NULL
cultures	NULL
throughout	NULL
the	NULL
culture	NULL
pe-riod	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
then	NULL
extracted	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
measured	NULL
by	NULL
EMSA	NULL
.	NULL

Arrows	NULL
indicate	NULL
specific	NULL
binding	NULL
to	NULL
NF-AT	NULL
(	NULL
A	NULL
)	NULL
,	NULL
AP-1	NULL
(	NULL
B	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
Oct-1	NULL
(	NULL
D	NULL
)	NULL
oligonucleo-tides	NULL
.	NULL

molecular	NULL
identification	NULL
of	NULL
the	NULL
GC	NULL
receptor	NULL
(	NULL
GR	NULL
)	NULL
.	NULL
``	NULL

GC	NULL
exerts	NULL
its	NULL
effects	NULL
through	NULL
binding	NULL
with	NULL
its	NULL
receptor	NULL
existing	NULL
in	NULL
the	NULL
cyto-plasm	NULL
.	NULL

GC-GR	NULL
complex	NULL
can	NULL
translocate	NULL
into	NULL
the	NULL
nucleus	NULL
and	NULL
bind	NULL
with	NULL
the	NULL
specific	NULL
enhancer	NULL
gene	NULL
segment	NULL
called	NULL
glucocorticoid	NULL
responsive	NULL
element	NULL
(	NULL
GRE	NULL
;	NULL
GGTACANNNTGTTCT	NULL
)	NULL
,	NULL
either	NULL
to	NULL
enhance	NULL
or	NULL
suppress	NULL
the	NULL
target	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
some	NULL
in-stances	NULL
,	NULL
GC-GR	NULL
complex	NULL
interferes	NULL
with	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
AP-1	NULL
,	NULL
a	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
composed	NULL
of	NULL
Jun	NULL
and	NULL
Fos	NULL
families	NULL
(	NULL
c-Jun	NULL
,	NULL
Jun-B	NULL
,	NULL
Jun-D	NULL
,	NULL
c-Fos	NULL
,	NULL
FosB	NULL
,	NULL
Fral	NULL
,	NULL
and	NULL
Fra	NULL
?	NULL
)	NULL

through	NULL
direct	NULL
protein-protein	NULL
interaction	NULL
.	NULL
``	NULL

''	NULL
The	NULL
inhibition	NULL
of	NULL
IL-2	NULL
enhancer	NULL
by	NULL
GC	NULL
maps	NULL
to	NULL
the	NULL
locus	NULL
containing	NULL
AP-1	NULL
element	NULL
.	NULL
``	NULL

It	NULL
is	NULL
also	NULL
reported	NULL
that	NULL
GC	NULL
interfere	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
through	NULL
induction	NULL
of	NULL
IB	NULL
synthesis	NULL
.	NULL
``	NULL

Our	NULL
present	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
previous	NULL
reports	NULL
that	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
the	NULL
targets	NULL
of	NULL
GC	NULL
actions	NULL
.	NULL

The	NULL
possible	NULL
location	NULL
of	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
responsible	NULL
for	NULL
the	NULL
GC	NULL
sensitivity	NULL
of	NULL
human	NULL
IL-5	NULL
gene	NULL
warrants	NULL
further	NULL
investigation	NULL
.	NULL

Because	NULL
the	NULL
CD3	NULL
molecule	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
complex	NULL
,	NULL
the	NULL
activation	NULL
signal	NULL
transduced	NULL
by	NULL
the	NULL
cross-linkage	NULL
of	NULL
CD3	NULL
molecules	NULL
is	NULL
considered	NULL
to	NULL
mimic	NULL
antigenic	NULL
stimuli	NULL
delivered	NULL
through	NULL
TCR	NULL
under	NULL
physiologic	NULL
con	NULL
2897	NULL
ditions	NULL
.	NULL
``	NULL

We	NULL
and	NULL
others	NULL
reported	NULL
that	NULL
IL-5	NULL
synthesis	NULL
of	NULL
human	NULL
PBMC	NULL
was	NULL
suppressed	NULL
by	NULL
GC	NULL
.	NULL
``	NULL

Because	NULL
GC	NULL
induce	NULL
anti-inflammatory	NULL
second	NULL
messengers	NULL
,	NULL
including	NULL
lipocortins	NULL
,	NULL
in	NULL
various	NULL
cell	NULL
populations	NULL
,	NULL
``	NULL
it	NULL
is	NULL
still	NULL
unclear	NULL
whether	NULL
the	NULL
suppressive	NULL
effect	NULL
of	NULL
GC	NULL
on	NULL
IL-5	NULL
production	NULL
is	NULL
a	NULL
direct	NULL
action	NULL
on	NULL
T	NULL
cells	NULL
or	NULL
an	NULL
indirect	NULL
one	NULL
.	NULL

Our	NULL
present	NULL
findings	NULL
indicate	NULL
that	NULL
GC	NULL
can	NULL
exert	NULL
their	NULL
effects	NULL
directly	NULL
on	NULL
T	NULL
cells	NULL
,	NULL
because	NULL
the	NULL
T-cell	NULL
preparations	NULL
used	NULL
in	NULL
our	NULL
study	NULL
consisted	NULL
of	NULL
more	NULL
than	NULL
98	NULL
%	NULL
pure	NULL
T-cell	NULL
populations	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
activating	NULL
signal	NULL
through	NULL
T-cell	NULL
receptor	NULL
complex	NULL
,	NULL
exogenous	NULL
IL-2	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
IL-5	NULL
synthesis	NULL
by	NULL
human	NULL
allergen-specific	NULL
T-cell	NULL
clones	NULL
.	NULL
``	NULL

Although	NULL
the	NULL
roles	NULL
of	NULL
Th2	NULL
cytokines	NULL
in	NULL
atopic	NULL
diseases	NULL
have	NULL
been	NULL
empha-sized	NULL
,	NULL
``	NULL
``	NULL
``	NULL
``	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
local	NULL
IL-2	NULL
production	NULL
was	NULL
also	NULL
enhanced	NULL
during	NULL
the	NULL
late	NULL
phase	NULL
reaction	NULL
after	NULL
allergen	NULL
exposure	NULL
,	NULL
``	NULL
``	NULL
``	NULL
``	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
IL-2	NULL
(	NULL
Th1	NULL
cytokine	NULL
)	NULL
in	NULL
addition	NULL
to	NULL
Th2Z	NULL
cytokines	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
atopic	NULL
diseases	NULL
.	NULL

So	NULL
it	NULL
is	NULL
an	NULL
intriguing	NULL
question	NULL
as	NULL
to	NULL
whether	NULL
IL-2-induced	NULL
IL-5	NULL
production	NULL
is	NULL
also	NULL
suppressed	NULL
by	NULL
GC	NULL
.	NULL

IL-2	NULL
induces	NULL
PTK	NULL
activation	NULL
and	NULL
PI-3	NULL
kinase	NULL
activation	NULL
,	NULL
but	NULL
neither	NULL
Ca**	NULL
mobilization	NULL
,	NULL
PI	NULL
turnover	NULL
,	NULL
nor	NULL
PKC	NULL
activation	NULL
occurs	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
stimulation	NULL
,	NULL
``	NULL
``	NULL
``	NULL
*	NULL
``	NULL
*	NULL
``	NULL
whereas	NULL
these	NULL
early	NULL
biochemical	NULL
events	NULL
are	NULL
the	NULL
hallmarks	NULL
of	NULL
TCR-mediated	NULL
T-cell	NULL
activation	NULL
.	NULL
``	NULL

'	NULL
TCR	NULL
signal	NULL
is	NULL
sensitive	NULL
to	NULL
FK506	NULL
and	NULL
cyclosporin	NULL
A	NULL
,	NULL
but	NULL
IL-2R	NULL
signal	NULL
is	NULL
not	NULL
,	NULL
``	NULL
``	NULL
indicating	NULL
that	NULL
cytokine	NULL
synthesis	NULL
induced	NULL
by	NULL
TCR	NULL
signal	NULL
is	NULL
transduced	NULL
by	NULL
a	NULL
quite	NULL
different	NULL
pathway	NULL
from	NULL
that	NULL
induced	NULL
by	NULL
IL-2R	NULL
signal	NULL
.	NULL

It	NULL
was	NULL
also	NULL
reported	NULL
that	NULL
TCR-induced	NULL
cytokine	NULL
production	NULL
was	NULL
inhibited	NULL
by	NULL
quite	NULL
low	NULL
concentrations	NULL
of	NULL
GC	NULL
,	NULL
but	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
the	NULL
proliferation	NULL
of	NULL
murine	NULL
cytotoxic	NULL
T	NULL
cells	NULL
induced	NULL
by	NULL
IL-2	NULL
was	NULL
affected	NULL
only	NULL
marginally	NULL
by	NULL
GC	NULL
,	NULL
``	NULL
suggesting	NULL
that	NULL
the	NULL
signals	NULL
mediating	NULL
cytokine	NULL
synthesis	NULL
use	NULL
different	NULL
pathways	NULL
from	NULL
those	NULL
mediating	NULL
IL-2-induced	NULL
cell	NULL
proliferation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
was	NULL
clearly	NULL
shown	NULL
here	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
not	NULL
only	NULL
the	NULL
proliferation	NULL
but	NULL
also	NULL
IL-5	NULL
synthesis	NULL
of	NULL
human	NULL
helper	NULL
T	NULL
cells	NULL
induced	NULL
by	NULL
IL-2	NULL
is	NULL
totally	NULL
suppressed	NULL
by	NULL
GC	NULL
.	NULL

These	NULL
findings	NULL
further	NULL
support	NULL
the	NULL
efficacy	NULL
of	NULL
GC	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
eosinophilic	NULL
inflammation	NULL
acting	NULL
as	NULL
IL-5	NULL
synthesis	NULL
inhibitors	NULL
.	NULL

GC	NULL
suppressed	NULL
the	NULL
expression	NULL
of	NULL
IL-5	NULL
mRNA	NULL
induced	NULL
by	NULL
IL-2	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
and	NULL
at	NULL
the	NULL
same	NULL
time	NULL
suppressed	NULL
the	NULL
gene	NULL
transcription	NULL
mediated	NULL
by	NULL
the	NULL
human	NULL
IL-5	NULL
promoter/enhancer	NULL
gene	NULL
located	NULL
5	NULL
'	NULL
upstream	NULL
of	NULL
the	NULL
coding	NULL
region	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
GC	NULL
exert	NULL
their	NULL
action	NULL
on	NULL
T	NULL
cells	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

EMSA	NULL
analysis	NULL
indicated	NULL
that	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
were	NULL
among	NULL
the	NULL
possible	NULL
targets	NULL
of	NULL
GC	NULL
action	NULL
on	NULL
TCR-stimulated	NULL
helper	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
.	NULL
``	NULL

''	NULL
Whether	NULL
the	NULL
effect	NULL
of	NULL
GC	NULL
on	NULL
IL-5	NULL
gene	NULL
specifically	NULL
maps	NULL
to	NULL
AP-1	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
element	NULL
within	NULL
human	NULL
IL-5	NULL
promoter/enhancer	NULL
gene	NULL
should	NULL
further	NULL
be	NULL
determined	NULL
by	NULL
the	NULL
transfection	NULL
analysis	NULL
using	NULL
mutant	NULL
promoter/enhancer	NULL
plas-mids	NULL
as	NULL
performed	NULL
in	NULL
IL-2	NULL
gene.60	NULL
AP-1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
NF-AT	NULL
binding	NULL
was	NULL
not	NULL
detectable	NULL
after	NULL
IL-ZR	NULL
stimulation	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
TCR	NULL
stimulation	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
endogenous	NULL
IL-5	NULL
gene	NULL
expression	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
and	NULL
transcriptional	NULL
activity	NULL
as	NULL
determined	NULL
by	NULL
pIL-5	NULL
(	NULL
-511	NULL
)	NULL
Luc	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
induced	NULL
by	NULL
either	NULL
TCR	NULL
or	NULL
IL-2R	NULL
stimulation	NULL
were	NULL
quite	NULL
comparable	NULL
,	NULL
suggesting	NULL
that	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activities	NULL
seem	NULL
to	NULL
be	NULL
important	NULL
for	NULL
IL-5	NULL
synthesis	NULL
induced	NULL
by	NULL
TCR	NULL
stimulation	NULL
,	NULL
but	NULL
are	NULL
not	NULL
essential	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2898	NULL
for	NULL
IL-5	NULL
synthesis	NULL
induced	NULL
by	NULL
IL-2	NULL
.	NULL

Because	NULL
the	NULL
induction	NULL
of	NULL
NF-AT	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
IL-2-stimulated	NULL
T	NULL
cells	NULL
may	NULL
follow	NULL
different	NULL
kinetics	NULL
than	NULL
in	NULL
TCR-stimulated	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
NF-AT	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activities	NULL
at	NULL
different	NULL
time	NULL
points	NULL
after	NULL
IL-2	NULL
and	NULL
TCR	NULL
stimulation	NULL
.	NULL

No	NULL
significant	NULL
binding	NULL
activities	NULL
of	NULL
NF-AT	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-xB	NULL
were	NULL
detected	NULL
at	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
and	NULL
4	NULL
hours	NULL
after	NULL
IL-2	NULL
stimulation	NULL
,	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
results	NULL
obtained	NULL
at	NULL
2	NULL
hours	NULL
(	NULL
shown	NULL
in	NULL
Fig	NULL
5	NULL
)	NULL
,	NULL
although	NULL
those	NULL
binding	NULL
activities	NULL
were	NULL
clearly	NULL
induced	NULL
by	NULL
TCR	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
present	NULL
findings	NULL
suggest	NULL
that	NULL
GC	NULL
may	NULL
exert	NULL
their	NULL
effects	NULL
through	NULL
affecting	NULL
a	NULL
still	NULL
unknown	NULL
transcription	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
other	NULL
than	NULL
AP-1	NULL
,	NULL
NF-AT	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
Oct-1	NULL
,	NULL
and	NULL
a	NULL
GC-sensitive	NULL
unique	NULL
transcription	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
might	NULL
regulate	NULL
human	NULL
IL-5	NULL
gene	NULL
activation	NULL
in	NULL
allergic	NULL
diseases	NULL
associated	NULL
with	NULL
eosinophilic	NULL
inflammation	NULL
such	NULL
as	NULL
asthma	NULL
and	NULL
atopic	NULL
dermatitis	NULL
.	NULL

To	NULL
date	NULL
,	NULL
several	NULL
transcription	NULL
elements	NULL
,	NULL
including	NULL
AP-1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
NF-AT	NULL
,	NULL
Oct-1	NULL
,	NULL
GATA	NULL
,	NULL
and	NULL
conserved	NULL
lymphokine	NULL
element	NULL
0	NULL
(	NULL
CLEO	NULL
)	NULL
,	NULL
have	NULL
been	NULL
indicated	NULL
by	NULL
the	NULL
EMSA	NULL
and	NULL
homology	NULL
search	NULL
analyses	NULL
.	NULL

``	NULL
``	NULL
*	NULL
``	NULL
``	NULL
NF-AT	NULL
binding	NULL
activity	NULL
was	NULL
induced	NULL
in	NULL
an	NULL
activated	NULL
murine	NULL
mast	NULL
cell	NULL
line	NULL
and	NULL
the	NULL
human	NULL
IL-5	NULL
sequence	NULL
between	NULL
-120	NULL
and	NULL
-98	NULL
corresponded	NULL
to	NULL
the	NULL
activity	NULL
.	NULL
``	NULL

''	NULL
Both	NULL
GATA	NULL
binding	NULL
element	NULL
located	NULL
-82	NULL
to	NULL
-62	NULL
and	NULL
CLEO	NULL
element	NULL
located	NULL
-56	NULL
to	NULL
-42	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
spontaneous	NULL
,	NULL
not	NULL
inducible	NULL
,	NULL
transcriptional	NULL
activity	NULL
expressed	NULL
in	NULL
an	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
virus-transformed	NULL
T-cell	NULL
line	NULL
.	NULL
``	NULL

Two	NULL
octamer	NULL
binding	NULL
sites	NULL
located	NULL
-244	NULL
to	NULL
-237	NULL
and	NULL
somewhere	NULL
between	NULL
-67	NULL
and	NULL
-30	NULL
were	NULL
also	NULL
identified	NULL
.	NULL
``	NULL

Our	NULL
results	NULL
showing	NULL
that	NULL
human	NULL
IL-5	NULL
promoter/enhancer-luciferase	NULL
gene	NULL
construct	NULL
transfected	NULL
to	NULL
T-cell	NULL
clones	NULL
was	NULL
transcribed	NULL
upon	NULL
stimulation	NULL
and	NULL
was	NULL
downregulated	NULL
by	NULL
dexamethasone	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
indicate	NULL
that	NULL
the	NULL
approximately	NULL
500-bp	NULL
human	NULL
IL-5	NULL
gene	NULL
segment	NULL
located	NULL
5	NULL
'	NULL
upstream	NULL
of	NULL
the	NULL
coding	NULL
region	NULL
contains	NULL
an	NULL
activation-inducible	NULL
enhancer	NULL
element	NULL
(	NULL
s	NULL
)	NULL
regulated	NULL
by	NULL
GC	NULL
.	NULL

Because	NULL
the	NULL
function	NULL
of	NULL
transcription	NULL
factors	NULL
is	NULL
context-dependent	NULL
,	NULL
it	NULL
is	NULL
essential	NULL
to	NULL
determine	NULL
(	NULL
1	NULL
)	NULL
whether	NULL
those	NULL
possible	NULL
elements	NULL
homologous	NULL
to	NULL
the	NULL
consensus	NULL
binding	NULL
sequences	NULL
of	NULL
known	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
NF-AT	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-KB	NULL
really	NULL
bind	NULL
their	NULL
corresponding	NULL
transcription	NULL
factors	NULL
and	NULL
(	NULL
2	NULL
)	NULL
whether	NULL
those	NULL
elements	NULL
and	NULL
transcription	NULL
factors	NULL
are	NULL
functionally	NULL
active	NULL
in	NULL
human	NULL
helper	NULL
T	NULL
cells	NULL
and	NULL
regulated	NULL
by	NULL
GC	NULL
.	NULL

The	NULL
studies	NULL
necessary	NULL
to	NULL
answer	NULL
these	NULL
questions	NULL
are	NULL
currently	NULL
being	NULL
undertaken	NULL
using	NULL
transient	NULL
transfection	NULL
systems	NULL
,	NULL
EMSA	NULL
,	NULL
and	NULL
footprint	NULL
analyses	NULL
using	NULL
genuine	NULL
human	NULL
IL-5	NULL
sequences	NULL
.	NULL

The	NULL
further	NULL
identification	NULL
of	NULL
IL-2-responsive	NULL
and	NULL
GC-sensitive	NULL
transcriptional	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
IL-5	NULL
promoter/enhancer	NULL
gene	NULL
will	NULL
improve	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
human	NULL
T-cell	NULL
IL-5	NULL
synthesis	NULL
and	NULL
may	NULL
facilitate	NULL
future	NULL
therapeutic	NULL
intervention	NULL
for	NULL
severe	NULL
atopic	NULL
diseases	NULL
by	NULL
the	NULL
development	NULL
of	NULL
selective	NULL
IL-5	NULL
synthesis	NULL
inhibitors	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Dr	NULL
S.	NULL
Morimura	NULL
for	NULL
helpful	NULL
discussion	NULL
,	NULL
Dr	NULL
W.A	NULL
.	NULL

Gray	NULL
for	NULL
reviewing	NULL
this	NULL
manuscript	NULL
,	NULL
and	NULL
M.	NULL
Komatsu	NULL
and	NULL
Y.	NULL
Shirai	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Sanderson	NULL
CJ	NULL
,	NULL
Campbell	NULL
HD	NULL
,	NULL
Young	NULL
IG	NULL
:	NULL
Molecular	NULL
and	NULL
cellular	NULL
biology	NULL
of	NULL
eosinophil	NULL
differentiation	NULL
factor	NULL
(	NULL
interleukin-5	NULL
)	NULL
and	NULL
its	NULL
effects	NULL
on	NULL
human	NULL
and	NULL
mouse	NULL
B	NULL
cells	NULL
.	NULL

Immunol	NULL
Rev	NULL
102:29	NULL
,	NULL
1988	NULL
MORI	NULL
ET	NULL
AL	NULL
2	NULL
.	NULL

Lopez	NULL
AF	NULL
,	NULL
Sanderson	NULL
CJ	NULL
,	NULL
Gamble	NULL
JR	NULL
,	NULL
Campbell	NULL
DH	NULL
,	NULL
Young	NULL
IG	NULL
,	NULL
Vadas	NULL
MA	NULL
:	NULL
Recombinant	NULL
human	NULL
interleukin	NULL
5	NULL
is	NULL
a	NULL
selective	NULL
activator	NULL
of	NULL
human	NULL
eosinophil	NULL
function	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
167:219	NULL
,	NULL
1988	NULL
3	NULL
.	NULL

Clutterbuck	NULL
EJ	NULL
,	NULL
Hirst	NULL
EMA	NULL
,	NULL
Sanderson	NULL
CJ	NULL
:	NULL
Human	NULL
interleukin-5	NULL
(	NULL
IL-5	NULL
)	NULL
regulates	NULL
the	NULL
production	NULL
of	NULL
eosinophils	NULL
in	NULL
human	NULL
bone	NULL
marrow	NULL
cultures	NULL
:	NULL
Comparison	NULL
and	NULL
interaction	NULL
with	NULL
IL-1	NULL
,	NULL
IL-3	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
GM-CSF	NULL
.	NULL

Blood	NULL
73:1504	NULL
,	NULL
1989	NULL
4	NULL
.	NULL

Gulbenkian	NULL
AR	NULL
,	NULL
Egan	NULL
RW	NULL
,	NULL
Fernandez	NULL
X	NULL
,	NULL
Jones	NULL
H	NULL
,	NULL
Kreutner	NULL
W	NULL
,	NULL
Kung	NULL
T	NULL
,	NULL
Payvandi	NULL
F	NULL
,	NULL
Sullivan	NULL
L	NULL
,	NULL
Zurcher	NULL
JA	NULL
,	NULL
Watnick	NULL
AS	NULL
:	NULL
Interleukin-5	NULL
modulates	NULL
eosinophil	NULL
accumulation	NULL
in	NULL
allergic	NULL
guinea	NULL
pig	NULL
lung	NULL
.	NULL

Am	NULL
Rev	NULL
Respir	NULL
Dis	NULL
146:263	NULL
,	NULL
1992	NULL
5	NULL
.	NULL

Mauser	NULL
PJ	NULL
,	NULL
Pitman	NULL
A	NULL
,	NULL
Witt	NULL
A	NULL
,	NULL
Fernandez	NULL
X	NULL
,	NULL
Zurcher	NULL
J	NULL
,	NULL
Kung	NULL
T	NULL
,	NULL
Jones	NULL
H	NULL
,	NULL
Watnick	NULL
AS	NULL
,	NULL
Egan	NULL
RW	NULL
,	NULL
Kreutner	NULL
W	NULL
,	NULL
Adams	NULL
GK	NULL
.	NULL

:	NULL
Inhibitory	NULL
effect	NULL
of	NULL
the	NULL
TRFK-5	NULL
anti-IL-5	NULL
antibody	NULL
in	NULL
a	NULL
guinea	NULL
pig	NULL
model	NULL
of	NULL
asthma	NULL
.	NULL

Am	NULL
Rev	NULL
Respir	NULL
Dis	NULL
148:1623	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Gleich	NULL
GJ	NULL
:	NULL
The	NULL
eosinophil	NULL
and	NULL
bronchial	NULL
asthma	NULL
:	NULL
current	NULL
under-standing	NULL
.	NULL

J	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
8§5:422	NULL
,	NULL
1990	NULL
7	NULL
.	NULL

Kay	NULL
AB	NULL
:	NULL
'	NULL
``	NULL
Helper	NULL
``	NULL
(	NULL
CD4*	NULL
)	NULL
T	NULL
cells	NULL
and	NULL
eosinophils	NULL
in	NULL
allergy	NULL
and	NULL
asthma	NULL
.	NULL

Am	NULL
Rev	NULL
Respir	NULL
Dis	NULL
145:822	NULL
,	NULL
1992	NULL
8	NULL
.	NULL

Bochner	NULL
BS	NULL
,	NULL
Bradley	NULL
B	NULL
,	NULL
Undem	NULL
J	NULL
,	NULL
Lichtenstein	NULL
LM	NULL
:	NULL
Immuno-logical	NULL
aspects	NULL
of	NULL
allergic	NULL
asthma	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
12:295	NULL
,	NULL
1994	NULL
9	NULL
.	NULL

Hamid	NULL
Q	NULL
,	NULL
Azzawi	NULL
M	NULL
,	NULL
Ying	NULL
S	NULL
,	NULL
Mogbel	NULL
R	NULL
,	NULL
Wardlaw	NULL
AJ	NULL
,	NULL
Corrigan	NULL
CJ	NULL
,	NULL
Bradley	NULL
B	NULL
,	NULL
Durham	NULL
SR	NULL
,	NULL
Collins	NULL
JV	NULL
,	NULL
Jeffery	NULL
PK	NULL
,	NULL
Quint	NULL
J	NULL
,	NULL
Kay	NULL
AB	NULL
:	NULL
Expression	NULL
of	NULL
mRNA	NULL
for	NULL
interleukin-5	NULL
in	NULL
mucosal	NULL
bronchial	NULL
biopsies	NULL
from	NULL
asthma	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
87:1541	NULL
,	NULL
1991	NULL
10	NULL
.	NULL

Robinson	NULL
DS	NULL
,	NULL
Ying	NULL
S	NULL
,	NULL
Bentley	NULL
AM	NULL
,	NULL
Meng	NULL
Q	NULL
,	NULL
North	NULL
J	NULL
,	NULL
Durham	NULL
SR	NULL
,	NULL
Kay	NULL
AB	NULL
,	NULL
Hamid	NULL
Q	NULL
:	NULL
Relationships	NULL
among	NULL
numbers	NULL
of	NULL
bronchoalveolar	NULL
lavage	NULL
cells	NULL
expressing	NULL
messenger	NULL
ribonucleic	NULL
acid	NULL
for	NULL
cytokines	NULL
,	NULL
asthma	NULL
symptoms	NULL
,	NULL
and	NULL
airway	NULL
methacholine	NULL
responsiveness	NULL
in	NULL
atopic	NULL
asthma	NULL
.	NULL

J	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
92:397	NULL
,	NULL
1993	NULL
11	NULL
.	NULL

Robinson	NULL
D	NULL
,	NULL
Hamid	NULL
Q	NULL
,	NULL
Bentley	NULL
A	NULL
,	NULL
Ying	NULL
S	NULL
,	NULL
Kay	NULL
AB	NULL
,	NULL
Durham	NULL
SR	NULL
:	NULL
Activation	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
increased	NULL
Th2	NULL
type	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
,	NULL
and	NULL
eosinophil	NULL
recruitment	NULL
in	NULL
bronchoalveolar	NULL
lavage	NULL
after	NULL
allergen	NULL
inhalation	NULL
challenge	NULL
in	NULL
patients	NULL
with	NULL
atopic	NULL
asthma	NULL
.	NULL

J	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
92:313	NULL
,	NULL
1993	NULL
12	NULL
.	NULL

Ohnishi	NULL
T	NULL
,	NULL
Kita	NULL
H	NULL
,	NULL
Weiler	NULL
D	NULL
,	NULL
Sur	NULL
S	NULL
,	NULL
Sedgwick	NULL
JB	NULL
,	NULL
Calhoun	NULL
WJ	NULL
,	NULL
Busse	NULL
WW	NULL
,	NULL
Abrams	NULL
JS	NULL
,	NULL
Gleich	NULL
GJ	NULL
:	NULL
IL-5	NULL
is	NULL
the	NULL
predominant	NULL
eosinophil-active	NULL
cytokine	NULL
in	NULL
the	NULL
antigen-induced	NULL
pulmonary	NULL
late-phase	NULL
reaction	NULL
.	NULL

Am	NULL
Rev	NULL
Respir	NULL
Dis	NULL
147:901	NULL
,	NULL
1993	NULL
13	NULL
.	NULL

Corrigan	NULL
CJ	NULL
,	NULL
Haczku	NULL
A	NULL
,	NULL
Gemou-Engesaeth	NULL
V	NULL
,	NULL
Doi	NULL
S	NULL
,	NULL
Kikuchi	NULL
Y	NULL
,	NULL
Takatsu	NULL
K	NULL
,	NULL
Durham	NULL
SR	NULL
,	NULL
Kay	NULL
AB	NULL
:	NULL
CD4	NULL
T-lymphocyte	NULL
activation	NULL
in	NULL
asthma	NULL
is	NULL
accompanied	NULL
by	NULL
increased	NULL
serum	NULL
concentrations	NULL
of	NULL
interleukin-5	NULL
.	NULL

Effect	NULL
of	NULL
glucocorticoid	NULL
therapy	NULL
.	NULL

Am	NULL
Rev	NULL
Respir	NULL
Dis	NULL
147:540	NULL
,	NULL
1993	NULL
14	NULL
.	NULL

Robinson	NULL
D	NULL
,	NULL
Hamid	NULL
Q	NULL
,	NULL
Ying	NULL
S	NULL
,	NULL
Bentley	NULL
A	NULL
,	NULL
Assoufi	NULL
B	NULL
,	NULL
Durham	NULL
S	NULL
,	NULL
Kay	NULL
AB	NULL
:	NULL
Prednisolone	NULL
treatment	NULL
in	NULL
asthma	NULL
is	NULL
associated	NULL
with	NULL
modulation	NULL
of	NULL
bronchoalveolar	NULL
lavage	NULL
cell	NULL
interleukin-4	NULL
,	NULL
interleukin-5	NULL
,	NULL
and	NULL
interferon-y	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

Am	NULL
Rev	NULL
Respir	NULL
Dis	NULL
148:401	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Schleimer	NULL
PR	NULL
:	NULL
Effects	NULL
of	NULL
glucocorticoids	NULL
on	NULL
inflammatory	NULL
cells	NULL
relevant	NULL
to	NULL
their	NULL
therapeutic	NULL
applications	NULL
in	NULL
asthma	NULL
.	NULL

Am	NULL
Rev	NULL
Respir	NULL
Dis	NULL
141:859	NULL
,	NULL
1990	NULL
16	NULL
.	NULL

Snyder	NULL
DD	NULL
,	NULL
Unanue	NULL
ER	NULL
:	NULL
Corticosteroids	NULL
inhibit	NULL
murine	NULL
Ia	NULL
expression	NULL
and	NULL
IL-1	NULL
production	NULL
.	NULL

J	NULL
Immunol	NULL
129:1803	NULL
,	NULL
1982	NULL
17	NULL
.	NULL

Vacca	NULL
A	NULL
,	NULL
Martinotti	NULL
S	NULL
,	NULL
Screpanti	NULL
I	NULL
,	NULL
Maroder	NULL
M	NULL
,	NULL
Felli	NULL
MP	NULL
,	NULL
Farina	NULL
AR	NULL
,	NULL
Gismondi	NULL
A	NULL
,	NULL
Santoni	NULL
A	NULL
,	NULL
Frati	NULL
L	NULL
,	NULL
Gulino	NULL
A	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
by	NULL
glucocorticoid	NULL
hor-mones	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
265:8075	NULL
,	NULL
1990	NULL
18	NULL
.	NULL

Staynov	NULL
DZ	NULL
,	NULL
Lee	NULL
TH	NULL
:	NULL
Expression	NULL
of	NULL
interleukin-5	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
after	NULL
activation	NULL
with	NULL
phorbol	NULL
myristate	NULL
ace-tate	NULL
.	NULL

Immunology	NULL
75:196	NULL
,	NULL
1992	NULL
19	NULL
.	NULL

Mori	NULL
A	NULL
,	NULL
Suko	NULL
M	NULL
,	NULL
Nishizaki	NULL
Y	NULL
,	NULL
Kaminuma	NULL
O	NULL
,	NULL
Kobayashi	NULL
S	NULL
,	NULL
Matsuzaki	NULL
G	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Ito	NULL
K	NULL
,	NULL
Tsuruoka	NULL
N	NULL
,	NULL
Okudaira	NULL
H	NULL
;	NULL
Interleukin-5	NULL
production	NULL
by	NULL
CD4*	NULL
T	NULL
cells	NULL
of	NULL
asthmatic	NULL
patients	NULL
is	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GC	NULL
EFFECT	NULL
ON	NULL
T-CELL	NULL
IL-5	NULL
GENE	NULL
TRANSCRIPTION	NULL
suppressed	NULL
by	NULL
glucocorticoids	NULL
and	NULL
the	NULL
immunosuppressants	NULL
FK506	NULL
and	NULL
cyclosporin	NULL
A.	NULL
Int	NULL
Immunol	NULL
7:449	NULL
,	NULL
1995	NULL
20	NULL
.	NULL

Blackwell	NULL
GJ	NULL
,	NULL
Carnuccio	NULL
R	NULL
,	NULL
Di	NULL
Rosa	NULL
M	NULL
,	NULL
Flower	NULL
RJ	NULL
,	NULL
Parente	NULL
L	NULL
,	NULL
Persico	NULL
P	NULL
:	NULL
Macrocortin	NULL
:	NULL
A	NULL
polypeptide	NULL
causing	NULL
the	NULL
anti-phospholipase	NULL
effect	NULL
of	NULL
glucocorticoids	NULL
.	NULL

Nature	NULL
287:147	NULL
,	NULL
1980	NULL
21	NULL
.	NULL

Hirata	NULL
F	NULL
,	NULL
Schiffman	NULL
E	NULL
,	NULL
Venkatasubramaniman	NULL
K	NULL
,	NULL
Salomen	NULL
D	NULL
,	NULL
Axelrod	NULL
J	NULL
:	NULL
A	NULL
phospholipase	NULL
A	NULL
,	NULL
;	NULL
inhibitory	NULL
protein	NULL
in	NULL
rabbit	NULL
neutro-phils	NULL
induced	NULL
by	NULL
glucocorticoids	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
77:2533	NULL
,	NULL
1980	NULL
22	NULL
.	NULL

Cloix	NULL
JF	NULL
,	NULL
Colard	NULL
O	NULL
,	NULL
Rothhut	NULL
B	NULL
,	NULL
Russo-Marie	NULL
F	NULL
:	NULL
Characterization	NULL
and	NULL
partial	NULL
purification	NULL
of	NULL
``	NULL
renocortins	NULL
``	NULL
:	NULL
Two	NULL
polypeptides	NULL
formed	NULL
in	NULL
renal	NULL
cells	NULL
causing	NULL
the	NULL
anti-phospholipase-like	NULL
action	NULL
of	NULL
glucocorticoids	NULL
.	NULL

Br	NULL
J	NULL
Pharmacol	NULL
79:313	NULL
,	NULL
1983	NULL
23	NULL
.	NULL

Coote	NULL
PR	NULL
,	NULL
Di	NULL
Rosa	NULL
M	NULL
,	NULL
Flower	NULL
RJ	NULL
,	NULL
Merett	NULL
M	NULL
,	NULL
Parente	NULL
L	NULL
,	NULL
Wood	NULL
JN	NULL
:	NULL
Detection	NULL
and	NULL
isolation	NULL
of	NULL
steroid-induced	NULL
antiphospholipase	NULL
protein	NULL
of	NULL
hight	NULL
molecular	NULL
weight	NULL
.	NULL

Br	NULL
J	NULL
Pharmacol	NULL
80:597	NULL
,	NULL
1983	NULL
24	NULL
.	NULL

Di	NULL
Rosa	NULL
M	NULL
,	NULL
Flower	NULL
RJ	NULL
,	NULL
Hirata	NULL
F	NULL
,	NULL
Parente	NULL
L	NULL
,	NULL
Russo-Marie	NULL
F	NULL
:	NULL
Anti-phospholipase	NULL
proteins	NULL
.	NULL

Prostaglandins	NULL
23:441	NULL
,	NULL
1984	NULL
25	NULL
.	NULL

Mori	NULL
A	NULL
,	NULL
Suko	NULL
M	NULL
,	NULL
Tsuruoka	NULL
N	NULL
,	NULL
Kaminuma	NULL
O	NULL
,	NULL
Ohmura	NULL
T	NULL
,	NULL
Nishizaki	NULL
Y	NULL
,	NULL
Ito	NULL
K	NULL
,	NULL
Okudaira	NULL
H	NULL
:	NULL
Allergen-specific	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
produce	NULL
IL-5	NULL
upon	NULL
stimulation	NULL
with	NULL
Th1	NULL
cytokine	NULL
,	NULL
IL-2	NULL
.	NULL

Int	NULL
Arch	NULL
Allergy	NULL
Immunol	NULL
107:220	NULL
,	NULL
1995	NULL
26	NULL
.	NULL

Broide	NULL
DH	NULL
,	NULL
Lots	NULL
M	NULL
,	NULL
Cuomo	NULL
AJ	NULL
,	NULL
Coburn	NULL
DA	NULL
,	NULL
Federman	NULL
EC	NULL
,	NULL
Wasserman	NULL
SI	NULL
:	NULL
Cytokines	NULL
in	NULL
symptomatic	NULL
asthma	NULL
airways	NULL
.	NULL

J	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
89:958	NULL
,	NULL
1992	NULL
27	NULL
.	NULL

Robinson	NULL
DS	NULL
,	NULL
Hamid	NULL
Q	NULL
,	NULL
Ying	NULL
S	NULL
,	NULL
Tsicopoulos	NULL
A	NULL
,	NULL
Barkans	NULL
J	NULL
,	NULL
Bentley	NULL
AM	NULL
,	NULL
Corrigen	NULL
C	NULL
,	NULL
Durham	NULL
SR	NULL
,	NULL
Kay	NULL
AB	NULL
:	NULL
Predominant	NULL
Th2-like	NULL
bronchoalveolar	NULL
T-lymphocyte	NULL
population	NULL
in	NULL
atopic	NULL
asthma	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
326:298	NULL
,	NULL
1992	NULL
28	NULL
.	NULL

Walker	NULL
C	NULL
,	NULL
Bode	NULL
E	NULL
,	NULL
Boer	NULL
L	NULL
,	NULL
Hancel	NULL
TT	NULL
,	NULL
Blaser	NULL
K	NULL
,	NULL
Virchow	NULL
JC	NULL
Jr	NULL
:	NULL
Allergic	NULL
and	NULL
nonallergic	NULL
asthmatics	NULL
have	NULL
distinct	NULL
patterns	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
cytokine	NULL
production	NULL
in	NULL
peripheral	NULL
blood	NULL
and	NULL
bronchoalveolar	NULL
lavage	NULL
.	NULL

Am	NULL
Rev	NULL
Respir	NULL
Dis	NULL
146:109	NULL
,	NULL
1992	NULL
29	NULL
.	NULL

Kay	NULL
AB	NULL
,	NULL
Ying	NULL
S	NULL
,	NULL
Varney	NULL
V	NULL
,	NULL
Gaga	NULL
M	NULL
,	NULL
Durham	NULL
SR	NULL
,	NULL
Mogbel	NULL
R	NULL
,	NULL
Wardlaw	NULL
AJ	NULL
,	NULL
Hamid	NULL
Q	NULL
:	NULL
Messenger	NULL
RNA	NULL
expression	NULL
of	NULL
the	NULL
cytokine	NULL
gene	NULL
cluster	NULL
,	NULL
interleukin	NULL
3	NULL
(	NULL
IL-3	NULL
)	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
and	NULL
granulocyte/	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
in	NULL
allergen-induced	NULL
late-phase	NULL
cutaneous	NULL
reactions	NULL
in	NULL
atopic	NULL
subjects	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
173:775	NULL
,	NULL
1991	NULL
30	NULL
.	NULL

Minami	NULL
Y	NULL
,	NULL
Kono	NULL
T	NULL
,	NULL
Miyazaki	NULL
T	NULL
,	NULL
Taniguchi	NULL
T	NULL
:	NULL
The	NULL
IL-2	NULL
receptor	NULL
complex	NULL
:	NULL
Its	NULL
structure	NULL
,	NULL
function	NULL
and	NULL
target	NULL
genes	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
11:245	NULL
,	NULL
1993	NULL
31	NULL
.	NULL

Takeshita	NULL
T	NULL
,	NULL
Asao	NULL
H	NULL
,	NULL
Ohtani	NULL
K	NULL
,	NULL
Ishii	NULL
N	NULL
,	NULL
Kumaki	NULL
S	NULL
,	NULL
Tanaka	NULL
N	NULL
,	NULL
Munakata	NULL
H	NULL
,	NULL
Nakamura	NULL
M	NULL
,	NULL
Sugamura	NULL
K	NULL
:	NULL
Cloning	NULL
of	NULL
the	NULL
y	NULL
chain	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
receptor	NULL
.	NULL

Science	NULL
257:379	NULL
,	NULL
1992	NULL
32	NULL
.	NULL

Taniguchi	NULL
T	NULL
:	NULL
Cytokine	NULL
signaling	NULL
through	NULL
nonreceptor	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Science	NULL
268:251	NULL
,	NULL
1995	NULL
33	NULL
.	NULL

Saltzman	NULL
EM	NULL
,	NULL
Thorn	NULL
RR	NULL
,	NULL
Casnellie	NULL
JE	NULL
:	NULL
Activation	NULL
of	NULL
a	NULL
tyrosine	NULL
protein	NULL
kinase	NULL
is	NULL
an	NULL
early	NULL
event	NULL
in	NULL
the	NULL
stimulation	NULL
of	NULL
lymphocytes	NULL
by	NULL
interleukin-2	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
263:6956	NULL
,	NULL
1988	NULL
34	NULL
.	NULL

Merida	NULL
I	NULL
,	NULL
Diez	NULL
E	NULL
,	NULL
Gaulton	NULL
GN	NULL
:	NULL
IL-2	NULL
binding	NULL
activates	NULL
a	NULL
tyro-sine-phosphorylated	NULL
-	NULL
phosphatidylinositol-3-kinase	NULL
.	NULL

J	NULL
Immunol	NULL
147:2202	NULL
,	NULL
1991	NULL
35	NULL
.	NULL

Turner	NULL
B	NULL
,	NULL
Rapp	NULL
U	NULL
,	NULL
App	NULL
H	NULL
,	NULL
Greene	NULL
M	NULL
,	NULL
Dobashi	NULL
K	NULL
,	NULL
Reed	NULL
J	NULL
:	NULL
Interleukin-2	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
p72-74	NULL
Raf-1	NULL
kinase	NULL
in	NULL
a	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:1227	NULL
,	NULL
1991	NULL
36	NULL
.	NULL

Graves	NULL
JD	NULL
,	NULL
Downward	NULL
J	NULL
,	NULL
Izquierdo-Pastor	NULL
M	NULL
,	NULL
Rayter	NULL
S	NULL
,	NULL
Warne	NULL
PH	NULL
,	NULL
Cantrell	NULL
DA	NULL
:	NULL
The	NULL
growth	NULL
factor	NULL
IL-2	NULL
activates	NULL
p21ras	NULL
proteins	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

J	NULL
Immunol	NULL
136:2470	NULL
,	NULL
1992	NULL
37	NULL
.	NULL

Shibuya	NULL
H	NULL
,	NULL
Yoneyama	NULL
M	NULL
,	NULL
Ninomiya-Tsuji	NULL
J	NULL
,	NULL
Matsumoto	NULL
K	NULL
,	NULL
Taniguchi	NULL
TP	NULL
:	NULL
IL-2	NULL
and	NULL
EGF	NULL
receptors	NULL
stimulate	NULL
the	NULL
hematopoietic	NULL
cell	NULL
cycle	NULL
via	NULL
different	NULL
signaling	NULL
pathways	NULL
:	NULL
Demonstration	NULL
of	NULL
a	NULL
novel	NULL
role	NULL
for	NULL
c-myc	NULL
.	NULL

Cell	NULL
70:57	NULL
,	NULL
1992	NULL
2899	NULL
38	NULL
.	NULL

Weiss	NULL
A	NULL
,	NULL
Imboden	NULL
J	NULL
,	NULL
Shoback	NULL
D	NULL
,	NULL
Stobo	NULL
J	NULL
:	NULL
Role	NULL
of	NULL
T3	NULL
surface	NULL
molecules	NULL
in	NULL
human	NULL
T-cell	NULL
activation	NULL
:	NULL
T-cell-dependent	NULL
activation	NULL
results	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
cytoplasmic	NULL
free	NULL
calcium	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
81:4169	NULL
,	NULL
1984	NULL
39	NULL
.	NULL

Mills	NULL
GB	NULL
,	NULL
Cheung	NULL
RK	NULL
,	NULL
Grinstein	NULL
S	NULL
,	NULL
Gelfand	NULL
EW	NULL
:	NULL
Interleukin	NULL
2-induced	NULL
lymphocyte	NULL
proliferation	NULL
is	NULL
independent	NULL
of	NULL
increases	NULL
in	NULL
cytosolic-free	NULL
calcium	NULL
concentrations	NULL
.	NULL

J	NULL
Immunol	NULL
134:2431	NULL
,	NULL
1985	NULL
40	NULL
.	NULL

Mills	NULL
GB	NULL
,	NULL
Stewart	NULL
DJ	NULL
,	NULL
Mellors	NULL
A	NULL
,	NULL
Gelfand	NULL
EW	NULL
:	NULL
Interleukin	NULL
2	NULL
does	NULL
not	NULL
induce	NULL
phosphatidylinositol	NULL
hydrolysis	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
136:3019	NULL
,	NULL
1986	NULL
41	NULL
.	NULL

Valge	NULL
VE	NULL
,	NULL
Wong	NULL
JGP	NULL
,	NULL
Datlof	NULL
BM	NULL
,	NULL
Sinskey	NULL
AJ	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
Protein	NULL
kinase	NULL
C	NULL
is	NULL
required	NULL
for	NULL
responses	NULL
to	NULL
T	NULL
cell	NULL
receptor	NULL
ligands	NULL
but	NULL
not	NULL
to	NULL
interleukin-2	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
55:101	NULL
,	NULL
1998	NULL
42	NULL
.	NULL

Redondo	NULL
JM	NULL
,	NULL
Lopez-Rivas	NULL
A	NULL
,	NULL
Vila	NULL
V	NULL
,	NULL
Cragoe	NULL
EJ	NULL
Jr	NULL
,	NULL
Fresno	NULL
M	NULL
:	NULL
The	NULL
role	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
lymphocyte	NULL
proliferation	NULL
-Exis-tence	NULL
of	NULL
protein	NULL
kinase	NULL
C-dependent	NULL
and	NULL
-independent	NULL
pathways	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
263:17467	NULL
,	NULL
1988	NULL
43	NULL
.	NULL

Liu	NULL
L	NULL
:	NULL
FK506	NULL
and	NULL
cyclosporin	NULL
,	NULL
molecular	NULL
probes	NULL
for	NULL
studying	NULL
intracellular	NULL
signal	NULL
transduction	NULL
.	NULL

Immunol	NULL
Today	NULL
14:290	NULL
,	NULL
1993	NULL
44	NULL
.	NULL

Bierer	NULL
BE	NULL
,	NULL
Mattila	NULL
PS	NULL
,	NULL
Standaert	NULL
RF	NULL
,	NULL
Herzenberg	NULL
LA	NULL
,	NULL
Bura-koff	NULL
SJ	NULL
,	NULL
Crabtree	NULL
GR	NULL
,	NULL
Schreiber	NULL
SL	NULL
:	NULL
Two	NULL
distinct	NULL
signal	NULL
transmission	NULL
pathways	NULL
in	NULL
T	NULL
lymphocytes	NULL
are	NULL
inhibited	NULL
by	NULL
complexes	NULL
formed	NULL
between	NULL
an	NULL
immunophilin	NULL
and	NULL
either	NULL
FK506	NULL
or	NULL
rapamycin	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:9231	NULL
,	NULL
1990	NULL
45	NULL
.	NULL

Dumont	NULL
FJ	NULL
,	NULL
Staruch	NULL
MJ	NULL
,	NULL
Koprak	NULL
SL	NULL
,	NULL
Melino	NULL
MR	NULL
,	NULL
Sigaland	NULL
NH	NULL
:	NULL
Distinct	NULL
mechanisms	NULL
of	NULL
suppression	NULL
of	NULL
murine	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
the	NULL
related	NULL
macrolides	NULL
FK-506	NULL
and	NULL
rapamycin	NULL
.	NULL

J	NULL
Immunol	NULL
144:25	NULL
,	NULL
1990	NULL
46	NULL
.	NULL

Gillis	NULL
S	NULL
,	NULL
Crabtree	NULL
GR	NULL
,	NULL
Smith	NULL
KA	NULL
:	NULL
Glucocorticoid-induced	NULL
inhibition	NULL
of	NULL
T	NULL
cell	NULL
growth	NULL
factor	NULL
production	NULL
.	NULL

I	NULL
.	NULL

The	NULL
effect	NULL
on	NULL
mito-gen-induced	NULL
lymphocyte	NULL
proliferation	NULL
.	NULL

J	NULL
Immunol	NULL
123:1624	NULL
,	NULL
1979	NULL
47	NULL
.	NULL

Yuuki	NULL
T	NULL
,	NULL
Okumura	NULL
Y	NULL
,	NULL
Ando	NULL
T	NULL
,	NULL
Yamakawa	NULL
H	NULL
,	NULL
Suko	NULL
M	NULL
,	NULL
Haida	NULL
M	NULL
,	NULL
Okudaira	NULL
H	NULL
:	NULL
Cloning	NULL
and	NULL
expression	NULL
of	NULL
cDNA	NULL
for	NULL
the	NULL
major	NULL
house	NULL
dust	NULL
mite	NULL
allergen	NULL
Der	NULL
f	NULL
II	NULL
in	NULL
Escherichia	NULL
coli	NULL
.	NULL

Agric	NULL
Biol	NULL
Chem	NULL
55:1233	NULL
,	NULL
1991	NULL
48	NULL
.	NULL

Mori	NULL
A	NULL
,	NULL
Suko	NULL
M	NULL
,	NULL
Kaminuma	NULL
O	NULL
,	NULL
Inoue	NULL
$	NULL
,	NULL
Ohmura	NULL
T	NULL
,	NULL
Nishizaki	NULL
Y	NULL
,	NULL
Nagahori	NULL
T	NULL
,	NULL
Asakura	NULL
Y	NULL
,	NULL
Hoshino	NULL
A	NULL
,	NULL
Okumura	NULL
Y	NULL
,	NULL
Sato	NULL
G	NULL
,	NULL
Ito	NULL
K	NULL
,	NULL
Okudaira	NULL
H	NULL
:	NULL
IL-15	NULL
promotes	NULL
cytokine	NULL
production	NULL
of	NULL
human	NULL
helper	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
156:2391	NULL
,	NULL
1995	NULL
49	NULL
.	NULL

Fukuda	NULL
Y	NULL
,	NULL
Hashino	NULL
J	NULL
,	NULL
Haruyama	NULL
M	NULL
,	NULL
Tsuruoka	NULL
N	NULL
,	NULL
Nakazato	NULL
H	NULL
,	NULL
Nakanishi	NULL
T	NULL
:	NULL
A	NULL
sandwich	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
for	NULL
human	NULL
interleukin-5	NULL
.	NULL

J	NULL
Immunol	NULL
Methods	NULL
143:89	NULL
,	NULL
1991	NULL
50	NULL
.	NULL

Chomezynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single	NULL
step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1978	NULL
51	NULL
.	NULL

Tanabe	NULL
T	NULL
,	NULL
Konishi	NULL
M	NULL
,	NULL
Mizuta	NULL
T	NULL
,	NULL
Noma	NULL
T	NULL
,	NULL
Honjo	NULL
T	NULL
:	NULL
Molecular	NULL
cloning	NULL
and	NULL
structure	NULL
of	NULL
the	NULL
human	NULL
interleukin-5	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
26216580	NULL
,	NULL
1987	NULL
52	NULL
.	NULL

Schreiber	NULL
E	NULL
,	NULL
Matthias	NULL
P	NULL
,	NULL
Muller	NULL
MM	NULL
,	NULL
Schaffner	NULL
W	NULL
:	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
17:6419	NULL
,	NULL
1989	NULL
53	NULL
.	NULL

Lee	NULL
W	NULL
,	NULL
Mitchell	NULL
P	NULL
,	NULL
Tjian	NULL
R	NULL
:	NULL
Purified	NULL
transcription	NULL
factor	NULL
AP-1	NULL
interacts	NULL
with	NULL
TPA-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
49:741	NULL
,	NULL
1987	NULL
54	NULL
.	NULL

Lenardo	NULL
MJ	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
NF-Kappa	NULL
B	NULL
:	NULL
A	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227	NULL
,	NULL
1989	NULL
55	NULL
.	NULL

O'Neill	NULL
EA	NULL
,	NULL
Fletcher	NULL
C	NULL
,	NULL
Burrow	NULL
CR	NULL
,	NULL
Heintz	NULL
N	NULL
,	NULL
Roeder	NULL
RG	NULL
,	NULL
Kelly	NULL
TJ	NULL
:	NULL
Transcription	NULL
factor	NULL
OTF-1	NULL
is	NULL
functionally	NULL
indentical	NULL
to	NULL
the	NULL
DNA	NULL
replication	NULL
factor	NULL
NF-III	NULL
.	NULL

Science	NULL
241:1210	NULL
,	NULL
1988	NULL
56	NULL
.	NULL

Emmel	NULL
EA	NULL
,	NULL
Verweij	NULL
CL	NULL
,	NULL
Durand	NULL
DB	NULL
,	NULL
Higgins	NULL
KM	NULL
,	NULL
Lacy	NULL
E	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Science	NULL
246:1617	NULL
,	NULL
1989	NULL
57	NULL
.	NULL

Altman	NULL
A	NULL
,	NULL
Coggeshall	NULL
KM	NULL
,	NULL
Mustelin	NULL
T	NULL
:	NULL
Molecular	NULL
events	NULL
mediating	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Adv	NULL
Immunol	NULL
48:227	NULL
,	NULL
1990	NULL
58	NULL
.	NULL

Bottomly	NULL
K	NULL
,	NULL
Davis	NULL
LS	NULL
,	NULL
Lipsky	NULL
PE	NULL
:	NULL
Measurement	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
interleukin	NULL
2	NULL
and	NULL
interleukin	NULL
4	NULL
,	NULL
in	NULL
Coligan	NULL
JE	NULL
,	NULL
Kruisbeck	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2900	NULL
AM	NULL
,	NULL
Margulies	NULL
DH	NULL
,	NULL
Shevach	NULL
EM	NULL
,	NULL
Strober	NULL
W	NULL
,	NULL
Coico	NULL
R	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Current	NULL
Protocols	NULL
in	NULL
Immunology	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
1994	NULL
,	NULL
unit	NULL
6.3	NULL
59	NULL
.	NULL

Northrop	NULL
JP	NULL
,	NULL
Crabtree	NULL
GR	NULL
,	NULL
Mattila	NULL
PS	NULL
:	NULL
Negative	NULL
regulation	NULL
of	NULL
Interleukin	NULL
2	NULL
transcription	NULL
by	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
175:1235	NULL
,	NULL
1992	NULL
60	NULL
.	NULL

Vacca	NULL
A	NULL
,	NULL
Felli	NULL
MP	NULL
,	NULL
Farina	NULL
AR	NULL
,	NULL
Martinotti	NULL
,	NULL
Maroder	NULL
M	NULL
,	NULL
Screpanti	NULL
I	NULL
,	NULL
Meco	NULL
D	NULL
,	NULL
Petrangeli	NULL
E	NULL
,	NULL
Frati	NULL
L	NULL
,	NULL
Gulino	NULL
A	NULL
:	NULL
Glucocorticoid	NULL
receptor-mediated	NULL
suppression	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
expression	NULL
through	NULL
impairment	NULL
of	NULL
the	NULL
cooperativity	NULL
between	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
AP-1	NULL
enhancer	NULL
elements	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
175:637	NULL
,	NULL
1992	NULL
61	NULL
.	NULL

Arya	NULL
SK	NULL
,	NULL
Wong-Staal	NULL
F	NULL
,	NULL
Gallo	NULL
RC	NULL
:	NULL
Dexamethasone	NULL
mediated	NULL
inhibition	NULL
of	NULL
human	NULL
T-cell	NULL
growth	NULL
factor	NULL
and	NULL
gamma-interferon	NULL
messenger	NULL
RNA	NULL
.	NULL

J	NULL
Immunol	NULL
133:273	NULL
,	NULL
1984	NULL
62	NULL
.	NULL

Boumpas	NULL
DT	NULL
,	NULL
Anastassiou	NULL
ED	NULL
,	NULL
Older	NULL
SA	NULL
,	NULL
Tsokos	NULL
GC	NULL
,	NULL
Nelson	NULL
DL	NULL
,	NULL
Balow	NULL
JE	NULL
:	NULL
Dexamethasone	NULL
inhibits	NULL
human	NULL
interleukin	NULL
2	NULL
but	NULL
not	NULL
interleukin	NULL
2	NULL
receptor	NULL
gene	NULL
expression	NULL
in	NULL
vitro	NULL
at	NULL
the	NULL
level	NULL
of	NULL
nuclear	NULL
transcription	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
87:1739	NULL
,	NULL
1991	NULL
63	NULL
.	NULL

Tobler	NULL
A	NULL
,	NULL
Meier	NULL
R	NULL
,	NULL
Seitz	NULL
M	NULL
,	NULL
Dewald	NULL
B	NULL
,	NULL
Baggiolini	NULL
M	NULL
,	NULL
Fey	NULL
MF	NULL
:	NULL
Glucocorticoids	NULL
downregulate	NULL
gene	NULL
expression	NULL
of	NULL
GM-CSF	NULL
,	NULL
NAP-1/IL-8	NULL
,	NULL
and	NULL
IL-6	NULL
,	NULL
but	NULL
not	NULL
of	NULL
M-CSF	NULL
in	NULL
human	NULL
fibroblasts	NULL
.	NULL

Blood	NULL
79:45	NULL
,	NULL
1992	NULL
64	NULL
.	NULL

Culpepper	NULL
JA	NULL
,	NULL
Lee	NULL
F	NULL
:	NULL
Regulation	NULL
of	NULL
IL-3	NULL
expression	NULL
by	NULL
glucocorticoids	NULL
in	NULL
cloned	NULL
murine	NULL
T	NULL
lymphocytes	NULL
.	NULL

J	NULL
Immunol	NULL
135:3191	NULL
,	NULL
1985	NULL
65	NULL
.	NULL

Wu	NULL
CY	NULL
,	NULL
Fargeas	NULL
C	NULL
,	NULL
Nakajima	NULL
T	NULL
,	NULL
Delespesse	NULL
G	NULL
:	NULL
Glucocorticoids	NULL
suppress	NULL
the	NULL
production	NULL
of	NULL
interleukin	NULL
4	NULL
by	NULL
human	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
21:2645	NULL
,	NULL
1991	NULL
66	NULL
.	NULL

Mori	NULL
A	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Dohi	NULL
M	NULL
,	NULL
Suko	NULL
M	NULL
,	NULL
Okudaira	NULL
H	NULL
,	NULL
Miya-moto	NULL
T	NULL
:	NULL
Interleukin-4	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

Int	NULL
Arch	NULL
Allergy	NULL
Appl	NULL
Immunol	NULL
95:282	NULL
,	NULL
1991	NULL
67	NULL
.	NULL

Hollenberg	NULL
SM	NULL
,	NULL
Weinberger	NULL
C	NULL
,	NULL
Ong	NULL
ES	NULL
,	NULL
Cerelli	NULL
G	NULL
,	NULL
Oro	NULL
A	NULL
,	NULL
Lebo	NULL
R	NULL
,	NULL
Thompson	NULL
EB	NULL
,	NULL
Rosenfeld	NULL
MG	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Primary	NULL
structure	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
functional	NULL
human	NULL
glucocorticoid	NULL
receptor	NULL
cDNA	NULL
.	NULL

Nature	NULL
318:635	NULL
,	NULL
1985	NULL
68	NULL
.	NULL

Lapointe	NULL
MC	NULL
,	NULL
Baxter	NULL
JD	NULL
:	NULL
Molecular	NULL
biology	NULL
of	NULL
glucocorticoid	NULL
hormone	NULL
action	NULL
,	NULL
in	NULL
Lapointe	NULL
MC	NULL
,	NULL
Baxter	NULL
JD	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Anti-Inflammatory	NULL
Steroid	NULL
Action-Basic	NULL
and	NULL
Clinical	NULL
Aspects	NULL
.	NULL

London	NULL
,	NULL
UK	NULL
,	NULL
Aca-demic	NULL
,	NULL
1989	NULL
,	NULL
p	NULL
3	NULL
MORI	NULL
ET	NULL
AL	NULL
69	NULL
.	NULL

Jonat	NULL
C	NULL
,	NULL
Rahmsdorf	NULL
HJ	NULL
,	NULL
Park	NULL
KK	NULL
,	NULL
Cato	NULL
ACB	NULL
,	NULL
Gebel	NULL
$	NULL
,	NULL
Ponta	NULL
H	NULL
,	NULL
Herrlich	NULL
H	NULL
:	NULL
Antitumor	NULL
promotion	NULL
and	NULL
antiinflammation	NULL
:	NULL
Down-modulation	NULL
of	NULL
AP-1	NULL
(	NULL
Fos/Jun	NULL
)	NULL
activity	NULL
by	NULL
glucocorticoid	NULL
hormone	NULL
.	NULL

Cell	NULL
62:1189	NULL
,	NULL
1990	NULL
70	NULL
.	NULL

Yang-Yen	NULL
HJ	NULL
,	NULL
Chambard	NULL
JC	NULL
,	NULL
Sun	NULL
YL	NULL
,	NULL
Smeal	NULL
T	NULL
,	NULL
Schmidt	NULL
TJ	NULL
,	NULL
Drouin	NULL
J	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Transcriptional	NULL
interference	NULL
between	NULL
c-jun	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
:	NULL
Mutual	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
due	NULL
to	NULL
direct	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Cell	NULL
62:1205	NULL
,	NULL
1990	NULL
71	NULL
.	NULL

Schule	NULL
R	NULL
,	NULL
Ranganajan	NULL
P	NULL
,	NULL
Kliewev	NULL
S	NULL
,	NULL
Ransome	NULL
LJ	NULL
,	NULL
Bolado	NULL
J	NULL
,	NULL
Yang	NULL
N	NULL
,	NULL
Verna	NULL
IM	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Functional	NULL
antagonism	NULL
between	NULL
oncoprotein	NULL
c-jun	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Cell	NULL
62:1217	NULL
,	NULL
1990	NULL
72	NULL
.	NULL

Auphan	NULL
N	NULL
,	NULL
Didonato	NULL
JA	NULL
,	NULL
Rosette	NULL
C	NULL
,	NULL
Helmberg	NULL
A	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Immunosuppression	NULL
by	NULL
glucocorticoids	NULL
:	NULL
Inhibition	NULL
of	NULL
NF-KB	NULL
activity	NULL
through	NULL
induction	NULL
of	NULL
IB	NULL
synthesis	NULL
.	NULL

Science	NULL
270:286	NULL
,	NULL
1995	NULL
73	NULL
.	NULL

Del	NULL
Prete	NULL
GF	NULL
,	NULL
De	NULL
Carli	NULL
M	NULL
,	NULL
D'Elios	NULL
M	NULL
,	NULL
Maestrelli	NULL
P	NULL
,	NULL
Ricci	NULL
M	NULL
,	NULL
Fabbri	NULL
L	NULL
,	NULL
Romagnani	NULL
S	NULL
:	NULL
Allergen	NULL
exposure	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
allergen-specific	NULL
Th2	NULL
cells	NULL
in	NULL
the	NULL
airway	NULL
mucosa	NULL
of	NULL
patients	NULL
with	NULL
allergenic	NULL
respiratory	NULL
disorders	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
23:1445	NULL
,	NULL
1993	NULL
74	NULL
.	NULL

Okudaira	NULL
H	NULL
,	NULL
Mori	NULL
A	NULL
,	NULL
Suko	NULL
M	NULL
,	NULL
Etoh	NULL
T	NULL
,	NULL
Nakagawa	NULL
H	NULL
,	NULL
Ito	NULL
K	NULL
:	NULL
Enhanced	NULL
production	NULL
and	NULL
gene	NULL
expression	NULL
of	NULL
IL-5	NULL
in	NULL
bronchial	NULL
asthma-	NULL
Management	NULL
of	NULL
atopic	NULL
diseases	NULL
with	NULL
agents	NULL
that	NULL
downregulate	NULL
IL-5	NULL
gene	NULL
transcription	NULL
.	NULL

ACI	NULL
News	NULL
6:19	NULL
,	NULL
1994	NULL
75	NULL
.	NULL

Karlen	NULL
S	NULL
,	NULL
Mordvinovy	NULL
VA	NULL
,	NULL
Sanderson	NULL
CJ	NULL
:	NULL
How	NULL
is	NULL
expression	NULL
of	NULL
the	NULL
interleukin-5	NULL
gene	NULL
regulated	NULL
?	NULL

Immunol	NULL
Cell	NULL
Biol	NULL
74:218	NULL
,	NULL
1996	NULL
76	NULL
.	NULL

Prieschl	NULL
EE	NULL
,	NULL
Gouilleux-Gruart	NULL
V	NULL
,	NULL
Walker	NULL
C	NULL
,	NULL
Harrer	NULL
NE	NULL
,	NULL
Baurmruker	NULL
T	NULL
:	NULL
A	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cell-like	NULL
transcription	NULL
factor	NULL
in	NULL
mast	NULL
cells	NULL
is	NULL
involved	NULL
in	NULL
IL-5	NULL
gene	NULL
regulation	NULL
after	NULL
IgE	NULL
plus	NULL
antigen	NULL
stimulation	NULL
.	NULL

J	NULL
Immunol	NULL
154:6112	NULL
,	NULL
1995	NULL
77	NULL
.	NULL

Yamagata	NULL
T	NULL
,	NULL
Nishida	NULL
J	NULL
,	NULL
Sasaki	NULL
R	NULL
,	NULL
Tanaka	NULL
T	NULL
,	NULL
Honda	NULL
H	NULL
,	NULL
Hirano	NULL
N	NULL
,	NULL
Mano	NULL
H	NULL
,	NULL
Yazaki	NULL
Y	NULL
,	NULL
Hirai	NULL
H	NULL
:	NULL
;	NULL
Of	NULL
the	NULL
GATA-binding	NULL
proteins	NULL
,	NULL
only	NULL
GATA-4	NULL
selectively	NULL
regulates	NULL
the	NULL
human	NULL
interleukin-5	NULL
gene	NULL
promoter	NULL
in	NULL
interleukin-5-producing	NULL
cells	NULL
which	NULL
express	NULL
multiple	NULL
GATA-binding	NULL
proteins	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:3830	NULL
,	NULL
1995	NULL
78	NULL
.	NULL

Gruart-Gouilleux	NULL
V	NULL
,	NULL
Engels	NULL
P	NULL
,	NULL
Sullivan	NULL
M	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
human	NULL
interleukin-5	NULL
gene	NULL
promoter	NULL
:	NULL
Involvement	NULL
of	NULL
octamer	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
gene	NULL
promoter	NULL
activity	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
25:1431	NULL
,	NULL
1995	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1997	NULL
89	NULL
:	NULL
2891-2900	NULL
Two	NULL
Distinct	NULL
Pathways	NULL
of	NULL
Interleukin-5	NULL
Synthesis	NULL
in	NULL
Allergen-Specific	NULL
Human	NULL
T-Cell	NULL
Clones	NULL
Are	NULL
Suppressed	NULL
by	NULL
Glucocorticoids	NULL
Akio	NULL
Mori	NULL
,	NULL
Osamu	NULL
Kaminuma	NULL
,	NULL
Matsunobu	NULL
Suko	NULL
,	NULL
Satoshi	NULL
Inoue	NULL
,	NULL
Takeo	NULL
Ohmura	NULL
,	NULL
Akihiko	NULL
Hoshino	NULL
,	NULL
Yumiko	NULL
Asakura	NULL
,	NULL
Keiji	NULL
Miyazawa	NULL
,	NULL
Toyokazu	NULL
Yokota	NULL
,	NULL
Yasushi	NULL
Okumura	NULL
,	NULL
Koji	NULL
Ito	NULL
and	NULL
Hirokazu	NULL
Okudaira	NULL
4	NULL
QM	NULL
“	NULL
Caw	NULL
,	NULL
.	NULL

A	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

®	NULL
``	NULL
Ctown®	NULL
@	NULL
``	NULL
20	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/89/8/2891	NULL
.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Immunobiology	NULL
and	NULL
Immunotherapy	NULL
(	NULL
5678	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

